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SUMMARY
- vil -
1. The prejunctional actions of a number of Ca^* channel 
antagonists were- investigated. Their effects were assessed 
on both nerve action potential (AP) conduction and neuro­
muscular transmission in the vas deferens and internal anal 
sphincter (i.a.s.) of the guinea-pig and in the rat anococcygeus 
Nerve APs were recorded extracellularly with a suction electrode 
and transmitter release measured by intracellular electrical 
recording of smooth muscle junction potentials and analysis
of the overflow of radiolabelled transmitter.
/ —4 \2. In high concentrations, verapamil (0.5 - 2 x 10 M), 
diltiazem (l - 8 x 10 ^M), amlodipine (0»5 - 2 x 10 ^M), 
nicardipine (0.5 - 1 x 10 ^M) and cobalt (4 - 6 x 10 ^M),
each inhibited stimulation (0.3 Hz, O.O3 - 0.3 ms, supramaximal 
voltage) -evoked APs in the hypogastric nerve fibres running
to the guinea-pig vas deferens in vitro. Nifedipine (l - 
3 X  10 ^M) was ineffective. It is possible that at these 
high concentrations, inhibition of APs was achieved by a 
local anaesthetic action, involving Na"*", rather than Ca^ "*" 
channel blockade. The APs were abolished by tetrodotoxin 
(TTX, 1 X 10 ^M) and lignocaine (0.3 - 2 x 10 ^m). However,
AP amplitude was reduced following Ca^^-withdrawal from the 
perfusing Krebs solution, suggesting that the antagonists 
may block a Ca^^ component in the AP.
3. APs, in response to stimulation (single pulses, 0.1 - O.3 
ms, supramaximal voltage), were inhibited vitro by verapamil 
(0.3 - 2 X  10 ^M), nifedipine (0.3 - 1 x 10 ^M) and cobalt 
(0.3 - 1.3 X 10 ^M) in the genito-femoral nerve fibres running
- VI11 -
to the rat anococcygeus. As in the hypogastric nerve, the 
antagonists may have inhibited AP conduction by blocking Na"^  
and/or Ca^^ channels.
4. The significance of the ability to block AP conduction 
in vitro was examined by studying vivo, in the anaesthetised 
guinea-pig, the effects of the organic compounds on AP conduction 
compared with those on the cardiovascular system. Verapamil 
(O.Ol - 0.3 mgkg ^ ), diltiazem (O.Ol - 0.3 mgkg ^) and amlodipine 
(0.1 - 1.6 mgkg ^ ), when given i.v., each failed to affect 
stimulation (0.2 Hz, 0.1 - O.5 ms, supramaximal voltage)-evoked 
APs, recorded from the hypogastric nerve fibres running to 
the vas deferens, at a time when blood pressure and heart rate 
were significantly depressed. Verapamil (l - 3 mgkg ^), 
injected close-arterially, however, inhibited the APs. The 
inhibition produced by verapamil was probably not due to an 
action on conduction itself, but rather to the prevention of 
preganglionic transmitter release. This was suggested by 
the ability of acetylcholine (O.Ol mg i.a.) to produce a 
spontaneous postganglionic AP discharge during blockade by 
verapamil (3 mgkg  ^ i.a.).
5» Postganglionic transmitter release, as measured iji vi tro 
by intracellularly-recorded junction potentials, and mechanical 
responses, were inhibited in each tissue by the Ca^^ channel 
antagonists.
The excitatory junction potentials (e.j.ps) and contractions 
in the guinea-pig vas deferens, evoked by field stimulation 
(3-20 pulses at 1 and 2 Hz, 0.1 - 0.3 ms, supramaximal voltage).
- IX -
were inhibited by verapamil (l - 2 x 10 M)» diltiazem 
(l - 5 X 10"^M), amlodipine (0.5 - 1 x 10”'^ M) and cobalt 
(l X 10 ^M). Nifedipine (3 x 10 M) failed to affect the 
e.j.ps, but inhibited the contractions.
The e.j.ps and contractions in the rat anococcygeus, 
in response to extrinsic nerve stimulation (3 pulses at 
3-20 Hz, 0.3 ms, supramaximal voltage), were inhibited by 
verapamil (O.l - 3 x lO^^M), nifedipine (O.Ol - 1 x 10 ^M) 
and cobalt (0.3 - 2 x 10 ^M).
The inhibitory junction potentials (i.j.ps) produced by 
field stimulation (single pulse and 3 pulses at 3 and 10 Hz,
0.3 ms, supramaximal voltage), the tone of the guinea-pig
1.a.s. and the spontaneous spike discharge were each inhibited 
by verapamil (O.Ol - 1 x 10 ^M), diltiazem (0.03 - 3 x 10 ^M), 
nifedipine (O.Ol - 3 x 10 M) and cobalt (1 x 10 M).
The concentrations of the organic agents required to 
inhibit the junction potentials in each tissue were similar 
to those which blocked nerve AP conduction, suggesting that 
this action was responsible for the inhibition of release. 
Cobalt, on the other hand, inhibited release at a concentration 
which failed to affect AP conduction. Thus, cobalt, unlike 
the organic antagonists, appeared to prevent release by acting 
at or near the nerve terminals. Each organic agent blocked, 
postjunctionally, the responses of the tissues in preference 
to those prejunctionally; the mechanical responses of each 
preparation and the spontaneous spike discharge in the i.a.s. 
were inhibited when release was little affected. Cobalt was
— X —
equally effective pre- and postjunctionally.
6. The effects of the antagonists on transmitter release 
were also measured directly by radiochemical analysis in 
the vas deferens and i.a.s. of the guinea-pig.
Stimulation (400-2000 pulses at 20 Hz, 0.5 ms, supramaximal
r>
voltage)-evoked H overflow from the nerves of the vas deferens,
incubated with [^ h ] -adenosine, was inhibited by the antagonists
at similar concentrations to those which blocked the junction
potentials. Superfusion with either diltiazem (5 x 10 ^M)
or cobalt (2 x 10 ^M) prevented ^H overflow. Nifedipine
(5 X 10 ^M), ineffective on nerve AP conduction and e.j.ps,
also failed to affect H overflow.
In the vas deferens incubated with [^h] -noradrenaline,
the stimulation (60 pulses at 1-20 Hz, 0.5 ms, supramaximal
voltage) - evoked ^H overflow was inhibited by cobalt (2 x 10 ^M)
Superfusion with either verapamil (O.l - 1 x 10 ^M), diltiazem
(0.5 - 1 X 10 ^M), amlodipine (0.05 - 1 x 10 ^M) or nifedipine 
/ —4 \(1 - 5 X 10 M) increased markedly the resting overflow of 
3
H, such that any effect of stimulation could not be easily
3
determined. This drug-induced release of H consisted mainly 
of the noradrenaline metabolite, 3>4—dihydroxyphenylglycol 
(DOPEG) and originated from the sympathetic nerves independently 
of extracellular Ca^ "^ . The effect may have been due to either 
a reserpine- or tyramine-like action.
Although the identity of the non-adrenergic, non-cholinergic 
(NANC) transmitter in the guinea-pig i.a.s. is unknown, results 
from electrical studies have suggested that adenosine 5'- 
triphosphate (ATP) is a strong possibility (him & Muir, I986).
XI —
Following incubation of the i.a.s. with [^h] -adenosine,
field stimulation (900 pulses at 2-20 Hz, 0.5 ms, supramaximal
3
voltage) of the NANC nerves produced an overflow of H. The 
overflow had a neural origin; it was prevented by TTX (l x 10 ^M) 
and Ca^^-withdrawal from the superfusing medium, but unaffected 
by paralysis of the muscle with verapamil (1 x 10 ^M). Further-
/ —4 \more, sodium nitroprusside (1 x 10 M), a directly-acting
3
muscle relaxant, failed to affect the resting H overflow.
/ —4 \Superfusion with verapamil (1 x 10 M) blocked the overflow
3
of H in response to stimulation.
7. The possibility that ATP is indeed the NANC transmitter 
in the guinea-pig i.a.s. was investigated. Chromatographic 
separation of the [^h] -compounds in the stimulation (2400 pulses 
at 20 Hz, 0.5 ms, supramaximal voltage)-evoked overflow from 
the i.a.s., incubated with [^h] -adenosine, however, showed 
that only hypoxanthine, adenosine 5'-monophosphate (AMP ) and 
adenosine 3*>5*-cyclic monophosphate (cAMP) were present.
The existence of these compounds may have been the result of 
ATP metabolism. The luciferase-luciferin assay failed to 
detect any release of intact ATP from the i.a.s., following 
field stimulation (lOO-lOOO pulses at 10 and 20 Hz, 0.2 ms, 
supramaximal voltage). In the vas deferens, ATP release was 
detected following field stimulation (200-2000 pulses at 10 
and 20 Hz, 0.2 ms, supramaximal voltage), but was associated 
with the contraction of the muscle per se; it was inhibited 
when the muscle was paralysed selectively with sucrose (0.37M).
-  X l l  -
The failure to detect neuronally-released ATP in the vas 
deferens and the i.a.s. possibly indicated that it was being 
metabolised; if indeed this substance is the NANC transmitter 
in both tissues.
8. It is concluded that organic Ca^ "*" channel antagonists 
act prejunctionally, albeit in high concentrations, to inhibit 
both nerve AP conduction and transmitter release in autonomically- 
innervated tissues. It is likely that release is inhibited 
by failure of the AP to reach the release sites. A local 
anaesthetic action may be involved. The organic agents block 
selectively the postjunctional responses in smooth muscle, 
implying that the Ca^^ channels at this site differ from 
those prejunctionally. Cobalt, in contrast to the organic 
antagonists, blocks release at the same time as it prevents 
the postjunctional responses, but before affecting AP 
conduction.
- 1 -
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THE ROLE OF Ca^+
is of fundamental importance in the regulation of 
many biological processes, including contraction of cardiac, 
smooth and skeletal muscle (Bolton, I986; Ebashi & Endo, I968; 
Herzig, I985), secretion of transmitters and hormones (Katz & 
Miledi, I965; Rubin, 1970), generation and conduction of nerve 
and muscle action potentials (Bolton, I986; Hagiwara, 1973; 
Hagiwara & Byerly, I98I; Tomita, I98I) and activation of enzymes 
(Cohen, I982). It is not surprising, therefore, that drugs 
which interfere with the Ca^ "*" economy of cells should have 
profound biological effects. This thesis is concerned with 
one such group of drugs, the Ca^^ channel antagonists. Of 
particular interest is the actions of these agents on autonomic 
neuromuscular transmission. To appreciate why the antagonists 
should affect this process, our understanding of the precise 
role of Ca^^ in autonomic neuromuscular transmission should 
be defined. For convenience, the involvement of Ca^^ will be 
discussed, first in terms of its prejunctional neuronal actions 
and then with respect to its postjunctional effects in smooth 
and cardiac muscle.
AT PREJUNCTIONAL SITES
(a) In the nerve action potential
Elucidation of the role of sodium (Na^) and potassium 
(K^) ions as the predominant carriers of the current underlying 
the nerve action potential (AP, Hodgkin & Huxley, 1952) was 
soon followed by evidence for an involvement of Ca^^ (for reviews
- 3 -
see Hagiwara, 1973; Hagiwara & Byerly, I98I; Kostyuk, I98I).
It is now clear that in some nerves, Ca^^, usually in conjunction 
with Na^, can carry part of the inward current of the AP, 
although to varying extents in different species. A basic 
requirement for the involvement of Ca^^ is that channels in 
the neuronal membrane are activated and allow its entry into 
the cell.
A role for Ca^ **" in the nerve AP, as in other cell functions, 
is biophysically ’plausible' due to its large electrochemical 
gradient across the plasma membrane. The extracellular 
concentration of Ca^^ ( ^ Ca^^j ^ ) is high (in the millimolar 
range, Blaustein, 1974), while that, free (i.e. unbound) within 
the cell ( ) , is low (approximately 10 Schweitzer &
Blaustein, I980), due to Ca^^ uptake into organelles (mainly 
the mitochondria and endoplasmic reticulum) and into systems 
which bind divalent cations (Baker, 1972, 1976).
The importance of Ca^^ in the nerve AP varies among 
different regions of the neurone, possibly reflecting the 
relative densities of Ca^^ and Na"*" channels at each site. In 
the nerve cell body, for example, Ca^ "*" contributes significantly 
to the generation of the AP of a variety of species, including 
the frog (Koketsu e_t ^ .  , I959), chick (Dichter & Fischbach,
1977)» mollusc (Oomura e_t aT. , I961) and pigeon (Llinas & Hess, 
1976). Ca^* involvement has also been identified in mammalian 
nerve cell bodies, e.g. mouse dorsal root ganglion (Matsuda e_t al.
- 4 -
1976, 1978; Ransom & Holz, 1977) and neuroblastoma cells 
(Spector e_t , 1973; Moolenaar & Specter, 1979) and Auerbach's 
plexus of the guinea-pig small intestine (Hirst & Spence, 1973; 
North, 1973)' The precise function of these Ca^^ currents in 
the nerve cell body is unclear. They may participate, probably 
together with Na^, in initiating the propagating AP in the axon 
and also in metabolic processes within the cell (Kostyuk, I98I), 
such as cyclic nucleotide synthesis (Rasmussen & Goodman, 1977; 
Schultz e_t aT. , 1973) and protein kinase activity (Greengard, 
1979; Schulman & Greengard, 1978).
Ca^ "*" currents also exist in the non-terminal portion of 
the nerve axon, although, unlike those in the cell body, 
generally do not carry a significant amount of charge in 
comparison to that carried by Na^ (Hodgkin & Keynes, 1957)»
Ca^ '*’ involvement has been identified in the axons of several 
species, e.g. the squid (Hodgkin & Keynes, 1957); snail (Eckert 
& Lux, 1977); barnacle (Edgington & Stuart, 1979) and Helix 
(Akaike et al., 1978); as well as in the postganglionic neurones 
of the rat superior cervical ganglion (McAfee & Yarowsky, 1979; 
Horn & McAfee, I98O).
Powerful Ca^^ currents have been demonstrated, however, 
in the terminal regions of nerve axons in the frog (ito & 
Komatsu, 1979); lobster (Kawai & Niwa, I980) and chick (Dunlap 
& Fischbach, 1978). It has been proposed, on the basis of the 
inhibitory action of removal of ^ and addition of the
inorganic Ca^^ channel antagonist, manganese, that Ca^^ may 
also be involved in the APs of the guinea-pig hypogastric nerve
- 5 -
fibres (Cunnane & Stjârne, 1984). Ca^* currents are stronger 
in the terminals than in the axon, presumably reflecting the 
role of Ca^ "*" in transmitter release (see next section), in 
addition to its ability to carry the charge of the propagating 
AP at this site (Hagiwara & Byerly, I98I; Kostyuk, I98I).
From the large number of experiments claiming to have 
identified neuronal Ca^ "*" currents, several criteria have been 
proposed which require to be satisfied to establish a role 
for Ca^* in the AP (Hagiwara, 1973; Hagiwara & Byerly, I98I). 
Thus, the AP should persist in the presence of tetrodotoxin 
(TTX) , which selectively inhibits Na"*" influx and following 
substitution of ^Ca^^j ^  with barium or strontium, but should 
be inhibited by inorganic Ca^^ channel antagonists such as 
manganese, cobalt and lanthanum. The overshoot or maximum rate 
of rise of the AP should be unaffected by replacing Na^ with 
an organic cation such as tris'*’, but vary directly with |^Ca^^ ^  
and the amount of Ca^^ entering should be measurably sufficient 
(e.g. by radiochemical analysis) to charge the membrane to 
the potential reached by the spike.
(b) In transmitter release
Ca^ "*" is vital in transmitter release (Blaustein, 1979; 
Douglas, 1974; Rubin, 1970). An influx of Ca^^ into the nerve 
terminal, following arrival of the AP, provides the signal 
for the release of transmitter into the synaptic cleft (Rubin,
1970).
Studies supporting a role for Ca^*, based primarily on
- 6 —
the effects of altering [ca^ "^ ] ^ , have involved both direct 
measurement of release by the assay of tissue effluent 
(radiochemically or spectrofluorimetrically) following nerve 
stimulation, and an indirect measure of effector responses.
Thus, it has been demonstrated that Ca^ "*" causes release of 
transmitter from nerves in all species, both primitive and 
developed. Of particular interest is the role of Ca^^ in 
transmission from sympathetic and parasympathetic nerves, 
where the release of noradrenaline, acetylcholine or the non- 
adrenergic , non-cholinergic (NANC) transmitter (or transmitters) 
is produced.
^-dependent noradrenaline release has been demonstrated 
directly in the rabbit heart (Hukovic & Muscholl, I962;
LOffelholz, 1967), cat spleen (Kirpekar & Misu, I967; Kirpekar 
& Wakade, I968), guinea-pig vas deferens (Nakazado & Onada,
1980) and rat atria (Keenan & Callanan, I98O). Acetylcholine 
release in the cat superior cervical ganglion (Douglas e_b aT. ,
1961; Harvey & Macintosh, 194o), guinea-pig intestine (Cerhards 
et al., 1964) and rabbit sinoatrial node (Vincenzi & West, I965) 
has also been shown to be dependent on |ca^^j ^ .
Postsynaptic potentials, recorded electrophysiologically, 
provide an indirect measure of transmitter release (Bennett,
1973; Bennett & McLachlan, 1972; Elmquist & Quastel, I965;
Holman & Weinrich, 1975)» These have been used to show a 
I^ Ca^ j^ ^ -dependent release in sympathetic nerves of the vas 
deferens of the guinea-pig (Kuriyama, 1964) and mouse (Einstein 
& Lavidis, 1984) and in parasympathetic terminals of the chick 
ciliary ganglion (Martin & Pilar, 1964) and squid stellate
- 7 -
ganglion (Charlton e;t , I982). The demonstration that
removal of j^ Ca^ j^ ^  reduces the mechanical responses of the 
rabbit ileum (Burn & Gibbons, 1964), atria (Burn & Gibbons,
1965) and ear artery (Farmer & Campbell, I967) to nerve 
stimulation but not to agonist addition has been suggested 
to provide further, indirect, evidence for Ca^^ involvement 
in release. A requirement for Ca^^ has also been demonstrated 
in NANC transmitter release in the guinea-pig small intestine 
(Holman & Weinrich, 1975); urinary bladder (Burnstock e_t al. ,
1978) and internal anal sphincter (him, 1985)»
Notwithstanding its importance, the precise role of Ca^ "*" 
in release is unclear. Ca^ "*" conductance in the nerve terminal 
increases when depolarization, produced by the AP or K"*" addition, 
reaches a critical level (Wakade & Wakade, I982). 'Voltage-
operated' channels (V.O.Cs), so-called because they are opened
2+ 2 +by depolarization, allow Ca influx. Ca , entering the
terminal down its electrochemical gradient (McGraw e_b aT. , I982),
triggers a burst of transmitter release (Llinas & Nicholson,
1975; Miledi, 1973; Miller, I985) by exocytosis of the vesicle
contents (Douglas, 1974). The release is transient and declines
within 1-2 ms (McGraw aT. , I982), probably due to an abrupt
fall in Ijca^ j^ (Katz & Miledi, I968) by buffering or sequestratio
(McGraw et al., I982). The link, however, between Ca^^ entry
and transmitter release remains obscure. Ca^^ may trigger
exocytosis by neutralizing opposing electrostatic forces
between the vesicle and cell membranes (Blioch e_t aT. , I968),
or by facilitating fusion of the granule with lipids in the
plasma membrane (Blaschko» I967). It is unlikely, however, 
that Ca^ '*’ acts directly on the vesicle (Rubin, I970), having 
little effect on isolated secretory granules (Banks, I966; 
Hillarp, 1958). An intermediate energy-requiring step, 
possibly involving the splitting of ATP may be responsible 
(Kirpekar ejb aT. , 1970; Rubin, 1970). ATPase is located in 
vesicle fractions (Germain & Proulx, I965) and ATP together 
with Ca^ "*" produces a more consistent release from isolated 
vesicles (Poisner & Trifaro, 1967). Theories of an interaction 
of Ca^ '*’ with calmodulin (De Lorenzo, I98I), synapsin I (Miller, 
1985)» adenosine 3 ’>5'-cyclic monophosphate (cAMP, Geschwind, 
1989)» prostaglandins (Ramwell a^., I966) and lysolecithin 
(Blaschko, I967) have been introduced as the step linking Ca^* 
entry to release. Elucidation of the mechanism involved requires 
further work.
AT POSTJUNCTIONAL SITES
The involvement of Ca^^ in postjunctional cellular activity 
was first suggested by Ringer (I883)» who demonstrated that 
the ion was required to maintain the beating of the frog heart 
in vitro. In subsequent experiments, Ca^^, in addition to its 
involvement in muscle contraction was shown to ’stabilize' the 
membranes of excitable cells. Addition of Ca^ "*" to a bathing 
saline (NaCl) solution reduced evoked contractions of the frog 
sartorius muscle (Mines, I908). This action of Ca^^ was not 
restricted to skeletal muscle; egg membranes disrupted by 
needle puncture were repaired only in the presence of ^
(Heilbrunn, 19^3); while sheep and calf Purkinje fibres were
_ 9 —
inactivated when ^ was increased four-fold (to 10.4 x 10
Weidmann, 1955)*
The term 'stabilization*, used to define these effects of 
Ca^ '*’, was, of necessity, vague ; the mechanisms involved were 
imprecisely understood. Stabilization suggested a resistance 
to stimulation on the part of the biological membrane being 
investigated. Membranes which had been stabilized had the 
following characteristics :-
(a) stronger currents were required for their stimulation,
(b) spontaneous activity in them was slowed or suppressed and
(c) conduction of impulses in them, blocked (Weidmann, 1955)»
"While the presence of Ca^ "*" stabilized biological membranes, 
removal of the cation produced an increase in excitability 
(or 'labilization'). Thus, spontaneous fibrillations were 
observed following withdrawal of ^Ca^^j ^  in both frog sartorius 
muscle (Adrian & Gelfan, 1933; Kuffler, 1944) and in sheep 
and calf Purkinje fibres ("Weidmann, 1955)»
Modern technology and the growth in knowledge have led 
to the replacement of the terms 'stabilizer' and 'labilizer' 
by more precise descriptions of the actions of Ca^*. Current 
views on the biological activity of the cation postjunctionally 
have emphasised, rather than diminished, its importance. They 
have been obtained largely from two types of investigation ;- 
(a) those which have examined, electrophysiologically, its role 
as a mediator of membrane conductance, and (b) those in which 
the availability of Ca^* has been linked to biochemical membrane 
transduction mechanisms. Together, the results obtained from
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each type of investigation provide the basis of our understanding 
of how Ca^ '*’ is involved in many cellular functions. Thus, in 
muscle contraction, hormone secretion and enzyme activation, 
a rise in , which provides the ultimate signal for
many processes, is achieved by a trans-membrane Ca^^ current, 
acting alone or in conjunction with a biochemical mobilization 
of Ca^^ from within the cell. It is likely that the relative 
importance of these electrophysiological and biochemical 
components varies in different tissues and in different types 
of cellular responses. Attempts to measure, simultaneously, 
their individual contribution to responses in the same cell, 
have been largely unsuccessful to date. Until this is achieved, 
it is reasonable to discuss them separately.
(a) Ca^* as a mediator of membrane conductance
An influx of Ca^ '*' is largely responsible for providing 
the current which underlies or controls the excitability of 
both smooth and cardiac muscle (Bolton, I986; Hagiwara & Byerly, 
I98I; Holman & Neild, 1979; Hurwitz, I986; Reuter, 1973; 
Trautwein, 1973)» Ca^^ currents are involved in most types of 
electrical activity observed. This applies to the resting 
membrane potential and to the action potentials (APs), whether 
spontaneous or evoked, and 'slow wave' depolarizations which 
may contribute to contractile responses of smooth muscle 
(Bolton, 1986; Casteels, I98I; Reuter, 1973, 1985; Tomita, I98I; 
Trautwein, 1973)»
For example, the presence of Ca^* in the extracellular 
fluid makes an important contribution to the maintenance of
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the resting membrane potential of cells (Casteels, I98I). An 
increase in ^Ca^^j ^  hyperpolarizes and a decrease depolarizes 
the membrane potential in, for example, the guinea-pig vas 
deferens (Bennett, I967) and taenia coli (Brading e_t ad., I969) 
and the rabbit main pulmonary artery (Casteels e_b ad., 1977)» 
These effects do not depend directly on the Na^-K* pump; the 
hyperpolarization with increased ^Ca^^j ^  occurs in the presence 
of ouabain (Casteels, I98I). However, Na^ is involved; the 
depolarization following reduction of [ca^^j ^  depends on its 
presence in the extracellular fluid (Brading e_fc a^., I969).
An interference with a Na^-Ca^^ exchange process (Bolton, I986), 
which allows the transportation of these cations across the 
plasma membrane in either direction, may be responsible for 
the alterations in membrane potential produced by changing
o-
Ca also contributes significantly to the active electrical 
responses of tissues. Inward Ca^^ currents, which raise j^ Ca^ j^ , 
are associated with contraction in both smooth and cardiac 
muscle and the secretion of hormones from glands. In smooth 
muscle, Ca^* currents are responsible for the generation of 
APs, whether spontaneous or evoked, in tissues as diverse in 
function as the taenia coli, portal vein, vas deferens, stomach, 
myometrium and ureter (Bennett, 1987; Bdlbring & Tomita, I97O; 
Holman, 1937; Kuriyama, 1970; Kuriyama ejb ad., 1971; Kuriyama & 
Tomita, 1970; Tomita, 1973)* The current underlying the 'slow 
wave' depolarizations, characteristic of some (particularly 
gastrointestinal) smooth muscles, is also carried by Ca^* in,
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for example, the cat, dog and guinea-pig stomach (Tomita,
1981). Ca^^ is not the only ion involved, however, in 'slow
+  24-waves'; Na together with Ca carries the current underlying
the depolarizations in the stomach of the cat and dog (E1-
Sharkawy e_fc ad., 1978; Papasova et ad., I968) and the jejunum
of the rabbit (El-Sharkawy & Daniel, 1973)'
Ca^^ also carries the current underlying the depolarization 
of the plateau component of the cardiac AP. The other, sharp 
spike-like component, which precedes the plateau, is the 
result of an inward movement of Na^, rather than Ca^ "*" (Reuter, 
1973) 1983; Trautwein, 1973; Weidmann, 1974). Ca^^ currents 
are also responsible for excitation at the sinoatrial and 
atrioventricular nodes (Noma _et ad., 1980a,b) and for the 
conduction, rhythmicity and excitability of Purkinje fibres 
(Reuter, 1967)»
It has been proposed that Ca^^ carries inward current into 
the cell by passing through V.Q.Cs. The influx of Ca^* through 
these channels is sensitive to the Ca^ "*" gradient across the 
membrane, unaffected by TTX and inhibited by inorganic Ca^^ 
channel antagonists, such as manganese and cobalt. Barium and 
strontium can replace Ca^^ as carriers of the inward current 
(Bfllbring & Tomita, 1970; Hotta & Tsukui, I968; Kohlhardt al. , 
1973; Nayler & Grinwald, I98I; Nonomura ad., I966). It is 
also apparent that in cardiac muscle the V.O.Cs open and close 
slowly, relative to the fast Na^ channels and are operational 
over a different voltage range (between -43 and -23 mV for Ca^*
and -80 and -30 mV for Na^).
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V.O.Cs are opened by membrane depolarization. This may
be achieved by the pacemaker activity characteristic of some
tissues, e.g. the guinea-pig taenia coli (Brading e_b ^ .  , I969)
and internal anal sphincter (him, I983; Lim & Muir, 1983)»
In general, however, the depolarization which opens the V.O.Cs
to allow Ca^”*" influx, arises from a different population of
channels. In cardiac muscle, it is the depolarization created
by the initial Na^ influx which is responsible, while in many
smooth muscles and hormone-secreting glands, so-called 'receptor-
operated* channels (R.O.Cs ) may be involved. These R.O.Cs are
opened by agonist/receptor combination independently of membrane
potential (Bolton, 1979» I986) and, together with Ca^ "*", may
admit other small ions (Bolton, 1979)» The R.O.Cs are presumably
responsible for generation of the e.j.ps observed in some smooth
muscles, e.g. in the guinea-pig vas deferens (Burnstock & Holman,
1961). If the e.j.ps reach a sufficient level of depolarization,
2 +the V.O.Cs are opened, Ca enters the cell and in so doing, 
carries the current underlying the AP (Bolton, I986). Even 
in tissues where APs are normally absent, e.g. in the rat 
anococcygeus (Creed e_t aT. , 1973) and the sheep carotid and 
rabbit ear arteries (Droogmans et^  aT. , 1977; Keatinge, 1964), 
a significant amount of Ca^ "*" may enter the cell through the 
V.O.Cs, opened by individual or summated e.j.ps (Bolton, I986).
Despite the importance of membrane depolarization, it is 
now clear that the responses in some tissues occur independently 
of changes in membrane potential and, by inference, without 
an influx of Ca^^ through V.O.Cs (Bolton & Large, I986). Thus, 
contractions, unaccompanied by membrane depolarization, are
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evident in the rabbit and the canine main pulmonary arteries 
and aortae, in response to either serotonin, noradrenaline 
or histamine (Somlyo & Somlyo, I968) and in the guinea-pig 
ileum to acetylcholine, histamine and substance P (Glossmann 
et al., 1982). Also, some depolarized tissues are capable of 
contracting when no further depolarization is possible, e.g. 
in response to carbachol in the guinea-pig taenia coli (Durbin 
& Jehkinson, 196la,b) and to acetylcholine and serotonin in 
the chick amnion, rat uterus, guinea-pig ileum and cat intestine 
(Evans ejb ad., 1958).
This voltage-independent mechanism of tension generation, 
termed 'pharmacomechanical'-, as distinct from 'electromechanical'- 
coupling, is thought to involve mobilization of Ca^ '*’ from within 
the cell (Berridge, 1985a; Somlyo & Somlyo, I968). Indeed, 
the importance of the release of intracellularly-stored Ca^ '*’ 
is now recognised (Berridge, 1985a,b; Bolton, I986; Wollheim,
1985). Upon reduction or removal of |ca^^j ^ , some smooth 
muscles are still capable of contracting, e.g. in response to 
addition in the guinea-pig taenia coli (imai & Takeda, I967) 
and circular muscle of the stomach antrum (Kuriyama e_t ad. ,
1975)» Responses to acetylcholine in the rabbit mesenteric artery 
(Kuriyama & Suzuki, 1978) and to noradrenaline in the pulmonary 
artery (ito et al., 1977) also remain following ^Ga^^j ^ -removal.
Ca^^ mobilization is not restricted to contraction. It 
is also involved in many other biological processes, including 
secretion of insulin from the P-cells of the pancreas in 
response to glucose and to cholinergic agonists (Wollheim, I985),
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glycogen breakdown in the liver, secretion of histamine from 
mast cells and prolactin from the pituitary gland, fertilization 
of sea urchin oocytes, DNA synthesis in lymphocytes and platelet 
aggregation (Berridge, 1985a,b; Berridge & Irvine, 1984).
Although the importance of intracellular mobilization of 
Ca^^ has been recognised for some time, the underlying mechanisms 
have only recently been uncovered. It is now clear that 
transduction pathways, located in the cell membrane and activated 
by agonist/receptor combination, regulate, principally through 
Ca^^, cell function. These will now be described.
(b) Ca^^ in transduction mechanisms
In molecular terms, the transduction pathways which have 
been identified involve a series of proteins within the cell 
membrane, each of which transmits information by inducing a 
conformational change in adjacent proteins (Fig. 1). Thus, 
agonist/receptor combination changes the shape of a transducer 
*G* protein, so-called because of its dependence on guanosine 
5 *“triphosphate (GTP) for its activity, which, in turn, activates 
an effector molecule located at the inner surface of the cell 
membrane. This results in the activation of small molecules or 
ions in the cytoplasm - the 'second messengers', which diffuse 
throughout the cell and interact with intracellular 'acceptor' 
proteins. These proteins change in shape and trigger the 
cellular response.
Two major transduction pathways are now recognised (Fig. 2); 
one employs the second messengers, Ca^^, inositol 1,4,5- 
trisphosphate and diacylglycerol, and the other, cAMP. Guanosine 
3*, 5 '-cyclic monophosphate (cGMP) also has a second messenger
Fig. 1 ; The transduction of an extracellular signal 
(i.e. an agonist) into an intracellularly-mediated 
response. Following agonist/receptor combination, a 
transducer *G' protein, dependent on GTP for its 
activity, changes its conformation. This stimulates 
an effector - an enzyme, which, following its activation 
catalyses the production of a second messenger. The 
second messenger combines with an acceptor protein to 
trigger the cellular response.
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Fig. 2: Diagrammatic representation of the two major
transduction pathways identified in the cell and their 
influence on the availability or activity of Ca^^. In 
the first; an agonist (A^) interacts with its receptor 
(R^) at the plasma membrane; changing the conformation 
of a 'G ' protein (G^); which results in activation of 
adenylate cyclase (AC). Adenylate cyclase catalyses 
the conversion of ATP to cAMP. cAMP binds to an acceptor 
protein (Acc.P) in the cytoplasm to initiate a cellular 
response; either directly; or by interacting with the 
second transduction pathway. In this second pathway; an 
agonist (A^) interacts with its receptor (R^); stimulating; 
firstly a 'G ' protein (G^) and then; in turn; a phospho­
diesterase (PDE); phospholipase 0. The phosphodiesterase 
catalyses the hydrolysis of phosphatidylinositoi 4;^- 
bisphosphate to diacylglycerol (DG) and inositol 1;4;5-
trisphosphate (lP„). Inositol 1; 4;5-trisphosphate
2 +mobilises intracellularly-stored Ca ; which then binds 
to its acceptor protein and triggers the cellular 
response. Guanylate cyclase (GC); in the cytoplasm; 
converts GTP to cGMP. Following interaction of cGMP with 
its acceptor protein; the availability and/or activity of 
Ca^ "*" may be influenced. In addition; ^Ca^^j^ may be 
raised by influx through either ‘voltage-operated’ 
channels (V.O.Cs); opened by membrane depolarization; 
or ‘receptor-operated’ channels (R.O.Cs); opened by 
agonist/receptor combination.
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role, although does not appear to be associated with a 
transduction mechanism in the cell membrane. An enzyme, 
guanylate cyclase, converts GTP, in the cytoplasm, into cGMP.
Of all these second messengers, Ca^^ has a pivotal role. In 
regulating cell function, Ca^^ is not only a second messenger 
in its own right, but is also influenced by the other compounds. 
Thus, inositol 1,4,3-trisphosphate is involved in the 
mobilization of Ca^ '*’, while cAMP and cGMP may influence both 
the availability of Ca^ "*" and its activity.
Our present understanding of the precise mechanisms 
involved in the mobilization of Ca^ '*’ stems from the observation 
(Hokin & Hokin, 1953) that, in the pigeon pancreas, acetylcholine 
increased the incorporation of radioactive phosphate into 
phosphatidylinositol, one of the phospholipid constituents of 
the cell membrane. Michell (1975) suggested that the change 
in phosphatidylinositol lipid turnover was responsible for 
generating the increase in ^ underlying the responses
to many agonists. It is now clear that the key event, following 
agonist/receptor interaction and activation of a G protein, 
is the hydrolysis of phosphatidylinositol 4,3-bisphosphate by 
a phosphodiesterase, phospholipase C, to give diacylglycerol 
and inositol 1,4,3-trisphosphate (Berridge, 1983b). Inositol 
1»4,3-trisphosphate diffuses into the cytoplasm and releases 
Ca^* from the endoplasmic reticulum (Biden e_fc al_. , 1984).
Its ability to do this was first recognised in rat pancreatic 
cells (Streb ^  I983) and has since been confirmed in
many other tissues, e.g. in the smooth muscle of the porcine 
coronary artery (Suematsu ejb ^ .  , 1984), in canine cardiac
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muscle (Hirata e_fc aT. , 1984) and in frog skeletal muscle 
(Vergara e_fc al., 1983); as well as in hepatocytes (Burgess
et al., 1984) and platelets (O'Rourke e_fc ad., 1983)» Mobilization 
of Ca^* by inositol 1,4,3-trisphosphate may contribute to such 
diverse cellular responses as smooth muscle contraction (Ochs, 
1986), the secretion of insulin from the P-cells of the pancreas 
(Wollheim, 1983); the light response in Limulus photoreceptors, 
fertilization in sea urchin and starfish oocytes and initiation 
of a chloride current in Xenopus oocytes (Berridge, 1983a,b; 
Berridge & Irvine, 1984). A particularly interesting possibility 
is that inositol 1,4,3-trisphosphate might be important in 
mobilizing Ca^^ for excitation-contraction coupling in skeletal 
muscle (Ochs, I986; Vergara e_fc ad., I983)' Depolarization of 
the T-tubule membrane may release inositol 1,4,3-trisphosphate, 
which could then diffuse to the sarcoplasmic reticulum to 
release Ca^ '*’ (Berridge, 1983a). Ca^^ entry through R.O.Cs, 
following agonist/receptor interaction, may also be dependent 
on inositol 1,4,3-trisphosphate, although this remains to be 
established.
Elucidation of the role of cAMP as a second messenger began 
with its discovery in 1957 (Sutherland & Rail). The transduction 
pathway, resulting in cAMP formation, has since been elucidated 
(see Gilman, 1984). The key event in the cell membrane, 
following receptor and then G protein activation, is the 
conversion of ATP to cAMP by adenylate cyclase (Fig. 2). It 
is now established that in many processes, cAMP provides the 
'fine tuning' in the cell by regulating the economy of Ca^^. 
cAMP, following its combination with a protein
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kinase, modulates the availability of Ca^^, governing such 
responses as heart rate and force of contraction, glycogen 
breakdown in skeletal muscle and liver, platelet activation 
and secretion of saliva (Berridge, 1985b; Bushfield e_b al. ,
1985 )• In cardiac muscle, cAMP stimulates the Ca^ "*" pump of 
the sarcoplasmic reticulum, which accelerates relaxation and 
allows the organelle to discharge a larger pulse of Ca^^ on 
the next beat (Berridge, 1985a). cAMP also reduces |ca^^j 
to relax smooth muscle, following P-adrenoceptor stimulation 
(Bolton, 1986): there is an increased storage of Ca^^ in skinned
smooth muscle (itoh e_fc ad. , I982) and in microsomes containing 
endoplasmic reticulum (Fitzpatrick & Szentivanyi, 1977; Webb 
& Bhalla, 1976). Ca^ "*" entry through V.O.Cs may also be inhibited
by cAMP (Meisheri & van Breemen, I982). In human platelets 
too, cAMP antagonises the mobilization of Ca^^ and stimulates 
its sequestration and/or extrusion (Bushfield et ad., I985;
Zavoico & Feinstein, 1984). The mechanism responsible may 
involve an interference by cAMP with the activity of phospholipase 
C (Lapetina _eib ^ .  , 1977) and in consequence, production of 
inositol 1,4,3-trisphosphate (Watson e_k ad., 1984) and Ca^ '*’ 
mobilization.
Although the precise role of cGMP in the cell is not well 
understood, it is clear that it too, can interact with Ca^^
(Fig. 2). Thus, in platelets, cGMP inhibits elevation of |ca^^j , 
possibly by interacting with phospholipase 0 activity (Nakashima 
et ad., 1986) and also stimulates sequestration or efflux of 
Ca^ "*" (MacIntyre ^  ^ .  , I983). cGMP may interact with Ca^*
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in the process of visual excitation, although this has yet
to be established (Waloga, I983).
Following the increase in ^, by whichever mechani
or combination of mechanisms, and its possible interaction 
with other second messengers, the functional response of the 
cell is initiated. The means by which Ca^^ achieves this 
will now be discussed, with respect to three important processes; 
muscle responses, enzyme activation and hormone secretion.
(i ) Muscle responses
The precise role of Ca^^ in the contraction of smooth 
and cardiac muscle differs. In smooth muscle, Ca^^ acts directly 
as an activator to trigger contraction, while in cardiac muscle 
it behaves as a derepressor, removing an inhibition to allow
the contractile machinery to operate.
In smooth muscle, Ca^ '*’ triggers contraction by binding 
to calmodulin, an important Ca^^-binding protein (Berridge,
1985a; Bolton, 1986; Herzig, 1984). Ca^^-calmodulin activates 
myosin light chain kinase, an enzyme which phosphorylates a 
thick protein filament composed of myosin, allowing the formation 
of cross-bridges with a thin filamentous protein, actin 
(Bagshaw, 1982; Bolton, I986; Herzig, 1984). As in skeletal 
muscle ('sliding filament theory'; Huxley & Hanson, 1954), 
actin and myosin are believed to slide over each other by 
cross-bridge cycling, thus generating tension. Ca^*, in 
addition to activating myosin light chain kinase, is also 
required by myosin ATPase to enhance the splitting of ATP, 
the energy source for cross-bridge cycling (Herzig, 1985)*
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There may be other, less important mechanisms by which 
Ca^^ regulates smooth muscle contraction (Bolton, I986). Some 
of these involve actin; purified actin binds Ca^^ and activates 
myosin ATPase (Marston, 1982; Marston , I98O). In some
smooth muscles, Ca^ "*" regulates actin-myosin interaction 
independently of phosphorylation; the rate of ATP splitting 
and muscle shortening (and hence cross-bridge cycling) declines 
with little change in myosin phosphorylation (Butler & Siegman, 
1983; Siegman e_fc aT., 1984). The reason for this may be that 
Ca^^ binds to leiotonin, a protein which triggers actin-myosin 
interaction without myosin phosphorylation (Ebashi e_b aT. ,
1982).
In cardiac muscle, Ca^ '*’ binds to troponin C, a regulatory 
protein, which is attached to actin filaments. Following the 
binding of Ca^ "*", troponin C changes shape, moving another 
protein, tropomyosin out of its inhibitory position on the 
actin molecule, thereby allowing interaction of actin with 
myosin (Herzig, 1984, 1985)» Cross-bridges are formed between 
actin and myosin and cross-bridge cycling, as in smooth muscle, 
generates tension. Some Ca^^ also binds to calmodulin, but 
in cardiac muscle, unlike in smooth muscle, the Ca^^-calmodulin 
complex seems to have only a modulatory function, affecting 
the velocity of cross-bridge cycling and hence of muscle 
shortening (Rtlegg e_t a^. , 1983)»
A fall in the free ^ initiates relaxation in both
smooth and cardiac muscle. In smooth muscle, this reduction 
results in the dissociation of Ca^^-calmodulin, which deactivates 
myosin light chain kinase causing dephosphorylation of myosin
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(Bolton, 1986). In cardiac muscle, Ca^"^-troponin C dissociates 
and tropomyosin returns to its inhibitory position on the 
actin filament (Herzig, 1984, I985). i be depleted
by sequestration in the sarcoplasmic reticulum or other 
intracellular organelles (itoh e_t ad., I982), by extrusion 
(Bdlbring & den Hertog, I980) or by a reduction in Ca^^ influx 
through V.O.Cs (Meisheri & van Breemen, I982).
(ii) Enzyme activity
The multitude of enzymes dependent on Ca^^ for their 
activity include myosin light chain kinase, Ca^^ and Mg^^- 
ATPase, phospholamban kinase, glycogen synthase kinase, cyclic 
nucleotide phosphodiesterase and tyrosine and tryptophan 
hydroxylase (Adelstein & Elsenberg, I98O; Imahori, 1982; Le 
Peuch e_t a^. , 1979; Payne & Soderling, I98O; Teo & Wang, 1973; 
Yamauchi _e^  ad., I98I). Although the cellular responses to 
these, and other Ca^^-dependent enzymes are diverse, including, 
for example, muscle contraction, Ca^^ sequestration and glycogen 
and neurotransmitter synthesis, the regulatory role of Ca^*, 
in the main, follows its combination with the same molecule - 
calmodulin (Cohen, I982). It is believed that four Ca^ '*’ binding 
sites on calmodulin must be occupied for activation of cyclic 
nucleotide phosphodiesterase and myosin light chain kinase 
(Adelstein, I98I), although this number may be different for 
other enzymes (Cohen, I982). The interaction changes the 
molecular conformation of calmodulin and this, in turn, stimulates 
enzyme combination and activation. Although the importance 
of this Ca^^-calmodulin interaction is firmly established.
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it is not yet clear if one molecule of Ca^^-calmodulin 
activates several different enzymes simultaneously or if 
each is stimulated by a different |ca^^j ^  (Cohen, 1982;
Kuznicki e_b al. , I981).
It is now recognised that although Ca^^-calmodulin 
interaction is required for the activity of most Ca^^—dependent 
enzymes, it is not essential for some. Protein kinase C, for 
example, is activated by Ca^* without the involvement of 
calmodulin or any related Ca^ "*" binding protein. Interaction 
of Ca^^ with diacylglycerol may be involved (Cohen, I982).
(iii) Hormone secretion
The many hormones dependent on a rise in for
their secretion include adrenaline, insulin, corticosteroids, 
vasopressin, oxytocin, prolactin, calcitonin and thyrotrophin 
(Rubin, I97O; Trifaro, 1977; Wollheim, I985; Wollheim & Sharp, 
1981). The mechanisms proposed to explain how Ca^ "*" induces 
hormone secretion are the same (with the exception of that 
applying to corticosteroid release) as those applied to neuro­
transmitter release (vide infra) . Ca^ '*’, by some, as yet unknown
mechanism, but probably involving an intermediate energy step 
(e.g. ATP splitting), triggers exocytosis of hormones (Trifaro, 
1977)* The dependence on Ca^^ for corticosteroid secretion is 
due to its requirement for the synthesis of the compounds, 
rather than for release per se (Rubin, 1970)• In the adrenal 
cortex, there are no intracellular organelles containing 
corticosteroids for release and it is likely that following
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adrenocorticotrophin stimulation, corticosteroids are synthesised 
de novo and then immediately secreted (Rubin, 19?0). The site 
of action may be within the mitochondrion, where many of the 
steps of the biosynthetic pathway from cholesterol to cortico­
sterone are carried out (Peron & McCarthy, I968).
Ca^* CHANNEL ANTAGONISTS
The comprehensive role of Ca^^ in cellular activity implies 
that any drug which interferes with the availability of this 
ion will, most likely, have profound effects on the cell.
Not surprisingly, one group of dings, the principal action of 
which is to prevent Ca^* influx into the cell, has been used, 
both to study the involvement of Ca^^ in many cellular processes 
and clinically to treat disorders, such as angina pectoris, 
hypertension and cardiac dysrrhythmias (Snyder & Reynolds, 1985)» 
The terminology of these drugs is confusing. Originally
designated 'Ca^^ antagonists’, several synonyms, such as
2+ 2+'slow-channel blockers', 'Ca channel antagonists', 'Ca -
entry blockers' and 'Ca^^-blockers' have been introduced to
describe them (Fleckenstein, I983; Janis & Scriabine, 1983;
Vanhoutte, I98I). The term, 'Ca^* channel antagonists', used
throughout this thesis, was recommended by the Nomenclature
Working Party of the British Pharmacological Society.
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HISTORY
2 +The first Ca channel antagonists were inorganic compounds. 
In 1869» magnesium (Mg^^, as the sulphate) was noted by Jolyet 
and Cahours to produce respiratory paralysis in dogs (see 
Aikawa, I963; Engbaek, 1948). In the presence of Mg^ "*"» 
stimulation, directly, but not indirectly via the sciatic 
nerve, resulted in muscle contraction; an effect attributed, 
at this time, to a * curare-like' action. The precise mechanism 
of the Mg^^-induced antagonism remained unknown for almost a 
century, when it was shown that the release of acetylcholine 
at the frog sartorius neuromuscular junction was related 
directly to ^Ca^^j ^  and inversely to ^ (del Castillo &
Engbaek, 1954). Ca^^ and Mg^^, it was claimed, in the rat 
phrenic nerve/diaphragm preparation, competed for the same 
neuronal release sites (Hubbard, I961).
Interaction with Ca^^ was evident with other alkaline 
earth metals. When substituted for Ca^^, strontium and barium 
each maintained the resting membrane potential and the 
excitability of nerve axons (Blaustein & Goldman, I968; Guttman, 
1940). On the other hand, some cations were predominantly 
antagonistic - the so-called 'inorganic Ca^^ channel antagonists’ 
Ca^* spikes in crayfish muscle were inhibited by manganese 
(Fatt & Ginsborg, 1958) and in a variety of tissues, including 
the cat ventricle (Kohlhardt ejk aT. , 1973); the rods of the 
toad retina (Fain , I98O) and the muscle fibres of the
barnacle (Hagiwara & Takahashi, I967), by cobalt, nickel, 
c admium and 1 an th anum.
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The widespread interest in Ca^^ channel antagonists, 
arising from their clinical importance in hypertension and 
associated disorders, is not, however, due to the availability 
of inorganic agents, but stems, rather, from the emergence of 
new, chemically-unrelated, organic compounds. Like several 
other clinically-important drugs, e.g. chlorpromazine, the 
sulphonamides, penicillin and warfarin, the pharmacological 
activity of these compounds was discovered entirely by chance 
(Fleckenstein, 1983)* The first members of this class were 
synthesised in I963 by the German pharmaceutical companies.
Knoll and Hoechst, in the search for clinically-useful coronary 
vasodilators. Two such compounds produced both a vasodilatation 
and a hitherto unexplained cardiodepressant effect. Both were 
given to Professor Albrecht Fleckenstein in Freiburg for further 
investigation. He demonstrated that each mimicked the cardiac 
effects of I^ Ca^ j^ ^ -withdrawal, inhibiting excitation-contraction 
coupling and reducing Ca^^-dependent high-energy phosphate 
utilization and oxygen consumption (Fleckenstein, I983)* The 
inhibitory effects were reversed by measures which increased 
the supply of Ca^ "*" to the contractile system, i.e. addition of 
either P-adrenoceptor agonists, cardiac glycosides or Ca^^ itself. 
These dings, later named 'verapamil' and 'prenylamine', were 
thought to interfere with the mediator function of Ca^ "*" in 
excitation-contraction coupling in the heart.
Interest in this new pharmacodynamic principle, soon to 
be called 'Ca^* channel antagonism', and the success of verapamil
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and prenylamine in the treatment of angina and coronary heart 
disease in Germany, led to the search for other, similarly- 
acting agents. In I968, Fleckenstein was approached by Dengel, 
the chief chemist of the Knoll company, to examine the effects 
of the 600th compound he had synthesised, 'D 60O ', a methoxy 
derivative of verapamil. It had similar actions to verapamil, 
but was more potent on both the myocardium and on smooth muscle. 
One year later, 'Bay a 1040' and 'Bay a 7168', synthesised by 
the Bayer Company, were noted to inhibit contractile activity 
in the myocardium. Fleckenstein confirmed that these compounds 
acted in a similar manner to verapamil and D 600. Bay a 1040 
and Bay a 7168, later named 'nifedipine' (Fleckenstein et al., 
1972) and 'niludipine' (Fleckenstein ejb ad., 1979) respectively, 
currently enjoy a prominent position in medicine.
The 1970s were noted in the field of drug development by a 
world-wide acceptance of the Ca^* channel antagonistic principle 
and by a rapid numerical growth of the Ca^^ channel antagonist 
family. To provide a degree of order and to assist 
the clinician's choice of agent from the many available, some 
means of classification was required; several have been 
attempted.
First, on the basis of their different potencies and 
selectivities in blocking electrophysiologically-measured Ca^* 
and Na^ currents in the myocardium, organic Ca^* channel 
antagonists have been classified into two groups (Fleckenstein, 
1983; Fleckenstein & Reuter, I985). The members of the first 
(e.g. verapamil, nifedipine and diltiazem) inhibited by 9O-IOO#
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and the second (e.g. prenylamine and fendiline) by 50-70%, 
the Ca^ "*" current, without affecting that mediated by Na"*".
A second classification, based on results from radioligand 
binding studies, recognised that three different binding sites 
existed in the plasma membrane of a number of tissues, such 
as the brain and skeletal and cardiac muscle (Glossmann et al., 
1982, 1985)» Compounds designated 'Class 1' (i.e. the
dihydropyridines such as nifedipine) were bound at one high- 
affinity site, 'Class 2' (i.e. verapamil and its derivatives) 
at another and 'Class 3 ’ (i.e. diltiazem), yet another. That 
different binding sites should be involved is not surprising, 
considering the diversity in the chemical structures of the 
organic antagonists (Fig. 3)* The binding sites communicate 
allosterically; combination at one site influences interaction 
at another (Glossmann aT., 1985)» Thus, the compounds in 
Class 2 inhibit, non-competitively, the binding of those in 
Class 1 by acting at their own site. Interestingly, Class 3 
compounds, following their combination, stimulate rather than 
inhibit binding of 'Class 1' agents.
A third classification was based on the effectiveness of 
BAY K 8644, a dihydropyridine Ca^^ agonist (Schramm & Towart, 
1985), to reverse the inhibitory effects of the antagonists 
on Ca^^-evoked contractions in the depolarized guinea-pig 
taenia coli (Spedding & Berg, 1984). Compounds in Class 1 
(e.g. nifedipine) were those producing an inhibition which was 
reversed competitively by BAY K 8644. The inhibitory effects 
of Class 2 compounds (e.g. verapamil and diltiazem), on the
CH- OCH3
CH3O Vc(CH2)3NCH2CH2-^  ^ 0 ^ 3  
CH(CH3)2
Verapamil
COOCH
Nifedipine
OCH
C H - N N -C H o -C H  = CH ■OCOCH
Flunarizine CH2CH2N(CH3)2
Diltiazem
Pi#. 3 : The structural formulae of the organic Ca^^ channel
antagonists, verapamil (a phenylalkylamine), nifedipine (a 
dihydropyridine), flunarizine (a diphenylalkylamine) and 
diltiazem (a benzothiazepine). As a consequence of their 
diverse chemical structures, it is unlikely that these agents 
have a common molecular site of action.
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other hand» were reversed by BAY K 8644 in a non-competitive 
manner, while those of Class 3 (e.g. flunarizine) were unaffected.
These classifications have proved valuable, providing 
some degree of order among an increasing number of compounds.
The demonstration that the compounds vary in potency and 
selectivity, possess different binding sites and produce 
characteristically-different functional responses has proved 
expedient, both pharmacologically and clinically. The classifi­
cations enable their dissimilarities to be described, if not 
necessarily explained and may be related clinically with the 
variable effectiveness of the compounds which has been demonstrated 
in the treatment of a number of disorders. Thus, although all 
the antagonists which are currently used are efficacious in 
alleviating hypertension, verapamil and diltiazem are undoubtedly 
superior anti-dysrrhythmic agents than nifedipine (Henry, I98O; 
Snyder & Reynolds, 1985)» However, it is clear that there are 
anomalies among the classifications. Thus, although the 
inhibitions by verapamil and diltiazem are each prevented by 
BAY K 8644, these compounds have opposite effects on dihydro­
pyridine binding (Glossmann aT., 1982; Spedding & Berg, 1984). 
However, stimulation of BAY K 8644 binding by diltiazem may 
explain why inhibition with this agent is reversed more 
effectively than that with verapamil.
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EFFECTS
2 +
Ca channel antagonists act both pre— and postjunctionally 
to influence autonomic neuromuscular transmission. Their 
postjunctional effects are particularly well characterised 
and, in the case of the organic compounds, important clinically. 
It is the postjunctional actions which underlie their effective­
ness in the treatment of disorders, such as angina pectoris, 
hypertension, cardiac dysrrhythmias and cerebral vasospasm 
(Braunwald, I98O; Halperin & Cubeddu, I986; Henry, I98O;
Snyder & Reynolds, I985). These postjunctional actions will 
be described first.
(a) Effects at postjunctional sites
The compounds inhibit, selectively, Ca^^-dependent 
electrical and mechanical responses, whether spontaneous or 
evoked, in cardiac and in both vascular and non-vascular smooth 
muscle (Fleckenstein, I983; French & Scott, I98I; Golenhofen, 
1981). In each tissue investigated, responses mediated by an 
influx of Ca^^ across the cell membrane, from the extracellular 
fluid, are prevented more effectively than those which involve 
the mobilization of the ion from intracellular storage sites 
(van Nueten & Vanhoutte, I98I).
The effects of Ca^^ channel antagonists are particularly 
marked on the cardiovascular system. In the isolated heart,
they produce a negative inotropic response by inhibiting the
2+ 2+inward Ca current of the AP. This reduces the amount of Ca
available to the intracellular contractile proteins (Millard 
et al., 1982; Nayler & Grinwald, I98I ). The rate of both
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sinoatrial node ('pacemaker') discharge and conduction at 
the atrioventricular node - themselves mediated by an influx 
of Ca ^ — are also reduced, resulting in a negative chronotropic 
response (Fleckenstein, I983; Fleckenstein—Grün et al., 1984).
In consequence, the antagonists reduce ATP utilization in the 
beating ventricles (Fleckenstein, 1983). This, in turn, lowers 
the cardiac oxygen requirement and thus, the demand on the heart 
( Fleck en stein-Grün e_fc al. , 1984).
The vascular component of the cardiovascular system is
also affected, both in vitro and in vivo. The compounds reduce 
2+the resting, Ca -dependent tone of vascular smooth muscle, 
including the coronary vasculature; the resulting vasodilatation 
lowers blood pressure (Halperin & Cubeddu, I986; Hof, 1985)- 
Ca^^ channel antagonists also oppose agonist-induced vaso­
constriction. Thus, K'*'-, Ca^ "*"- and noradrenaline-evoked responses 
are prevented in a variety of isolated blood vessels, including 
the human, rabbit and rat mesenteric arteries, the rat and 
rabbit aortae and the pig coronary artery (Fleckenstein, I983; 
Godfraind & Dieu, I98I; Godfraind & Kaba, 1969; van Breemen 
et al., 1981).
In vivo, their effects on the blood vessels activate 
homeostatic mechanisms (Hof, I983). For example, the vaso­
dilatation produced by the compounds reflexly increases both 
heart rate and contractility. The extent to which the reflex 
overcomes the direct cardiac depressant effects of the compounds 
varies with each antagonist, reflecting, presumably, their 
relative potencies on cardiac and vascular smooth muscle.
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The response produced by each compound also varies among 
species and between conscious and anaesthetised animals.
In conscious dogs, for example, nifedipine increases, verapamil 
decreases and diltiazem fails to affect the force of myocardial 
contraction, although each accelerates heart rate (Millard 
et al., 1982). In anaesthetised animals, heart rate is reduced 
by each (Millard et al., I982). In anaesthetised cats, 
verapamil and diltiazem, but not nifedipine, each reduces 
heart rate (Hof, 1985)» In conscious humans, verapamil increases 
and diltiazem decreases heart rate; neither normally affects 
the force of myocardial contraction (Henry, I980). Such 
differences may be important clinically. A reflex tachycardia 
would, for example, be undesirable if cardiac dysrrhythmias 
were already present.
In non-vascular smooth muscle also, Ca^* channel antagonists 
inhibit spontaneous electrical activity, whether manifested 
as an AP discharge, as in the guinea-pig taenia coli (Tomita,
1981) and internal anal sphincter (him & Muir, I983), or as a 
slow membrane depolarization, as in the rat uterus (Reiner & 
Marshall, 1975) and the guinea-pig trachea (Ahmed ejb aT. , 1985)* 
Accompanying spontaneous mechanical activity is also inhibited. 
Interestingly, in tissues where biphasic mechanical responses 
are evident, the effectiveness of individual antagonists 
against the phasic and the tonic component differs. Thus, 
in a variety of tissues in the guinea-pig, verapamil, D 6OO 
and nifedipine each inhibit the phasic component of the 
contractions selectively (Golenhofen, I981). The tonic component 
may be resistant as a result of its relying on the mobilization 
of intracellular stores of Ca^*, rather than on trans-membrane
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flux, against which, the antagonists, in the main, are 
relatively ineffective (van Nueten & Vanhoutte, I98I).
Evoked contractions, in response to a number of stimuli, 
are also inhibited in non-vascular smooth muscle by Ca^ '*’ 
channel antagonists, again to varying extents. Responses to 
either addition or electrical stimulation are blocked 
readily in a variety of tissues, such as the rodent vas deferens 
(Blakeley e_t ad., I98I) and the guinea-pig ileum (Frankish,
1983)» while those to receptor agonists are little affected 
in most preparations, e.g. in the rat anococcygeus to noradrenaline 
(Oriowo, 1984) and in the guinea-pig trachea to either 
acetylcholine, histamine or serotonin (Advenier e^ ad., 1984).
This may be due to the ability of K^-depolarization and 
receptor agonists to utilize different channels - V.O.Cs and 
R.O.Cs respectively (Bolton, 1979» I986). This does not 
explain, however, why the antagonists should more effectively 
inhibit responses mediated by nerve stimulation, which presumably 
utilizes R.O.Cs, than by receptor agonists. Exogenously-added 
agonists could, possibly, prolong the open time of the R.O.Cs 
or, alternatively, may rely to a greater extent on intra- 
cellularly-bound Ca^^. Such suggestions are plausible; 
confirmation awaits experimental investigation.
(b) Effects at prejunctional sites
By comparison with their postjunctional activity, little 
attention has been paid to the prejunctional effects of Ca^* 
channel antagonists. Their postjunctional activity, giving 
rise to their clinical success, has held the stage of experimental
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endeavour. The lack of interest in their prejunctional actions 
is, however, surprising in the light of Ca^ '*’ involvement in 
both transmitter release and in the AP of some nerves (vide 
infra). The few prejunctional studies which have been carried 
out have confirmed that the antagonists affect both AP 
conduction and transmitter release (Andersson e_t a d . ,  1983; 
Cunnane & Stjâme, 1984; Takata & Kato, 1984). The organic 
compounds appear to be less active pre- than postjunctionally, 
inhibiting contractile responses in concentrations too small 
to affect release (Andersson e_b a d . ,  1983; Haeusler, 1972; 
Hëgestâtt e_t a d . ,  1982; Kajiwara & Casteels, I983).
Both organic (i.e. D 600) and inorganic (i.e. manganese 
and lanthanum) antagonists inhibit AP conduction in small 
preterminal sympathetic nerve fibres running to the guinea-pig 
vas deferens (Cunnane & Stjârne, 1984). This action is not 
restricted to autonomic nerves; verapamil and D 600 also 
inhibit APs in the somatic fibres of the rat phrenic nerve 
(Hay & Wadsworth, I982).
The effects of the compounds on transmitter release appear 
to vary in different tissues. In most, they produce an 
inhibition. Thus, release, measured radiochemically, in 
response to either electrical stimulation or K —depolarization, 
is reduced in the rabbit urethra (Andersson e^ , I983) and 
heart (COthert e_t , 1979), the canine saphenous vein 
(Takata & Kato, 1984) and guinea-pig portal vein (O'Connor,
1982). The reduction in inhibitory junction potential (i.j.p.) 
amplitude in the guinea-pig ileum may also be due to an
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interference with release (Bernstein ejb ad., I983).
In contrast, the organic compounds may, in some cases, 
potentiate transmitter release. Stimulation-evoked [^ h] - 
noradrenaline release, for example, is increased in the rat 
tail artery (Wolchinsky & Zsoter, I985) and rabbit ear artery 
(Steinsland et ad., I985), while i.j.p. amplitude is enhanced 
in the guinea-pig ileum at a lower concentration than that 
producing an inhibition (Bornstein a^., 1985)» The underlying 
mechanism of this potentiation is unclear. It may be mediated 
intracellularly independent of Ca^* (Wolchinsky & Zsoter, I983) 
or, at least in some cases, could involve a prejunctional 
inhibition of a^-adrenoceptors (Galzin & Langer, I983), thus 
removing a negative feedback control on release.
It is clear, however, that in some tissues, the organic 
antagonists (particularly nifedipine) are inactive. Thus, 
stimulation-evoked noradrenaline release in the guinea-pig 
portal vein (O'Connor, I982), rabbit urethra (Andersson ejk al. ,
1983) and ear artery (Steinsland e_fc ad., I985) and e.j.ps in 
the guinea-pig vas deferens (Blakeley et al., I98I) are 
unaffected by either nifedipine or nitrendipine.
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MECHANISM OF ACTION
Ca^* channel antagonists could, theoretically, interfere 
with Ca^^-dependent responses at pre- and postjunctional sites, 
either by inhibiting the influx of Ca^ '*’ from the extracellular 
fluid, the mobilization of the ion from intracellular stores, 
or by stimulating its efflux from, or sequestration within the 
cell. That Ca^^ channel antagonists produce their effects 
principally by inhibiting Ca^* influx is now established 
(Fleckenstein, 1977, 1983; Janis & Scriabine, 1983; Kohlhardt 
et al. , 1973; Reuter, I983; Schramm & Towart, I983). However, 
inhibition of both the mobilization of Ca^ "*" and its activity 
within the cell has also been demonstrated (Morgan ad. ,
1983; Rahwan, I985).
Evidence suggesting that the antagonists inhibit Ca^ "*" 
influx across the plasma membrane has arisen from both direct 
and indirect investigation in a variety of tissues. The 
inward, Ca^^-mediated current, measured electrophysiologically, 
is inhibited in both cardiac and smooth muscle cells (Ehara & 
Kaufmann, 1978; Lee & Tsien, 1983; Osterrieder et, , I98I; 
Reuter, I983). Also, ^^ Ca^ "*" uptake is prevented in a variety 
of tissues, including the rabbit aorta (van Breemen _et al. , 
1981) and the rat aorta and mesenteric artery (Godfraind &
Dieu, I98I).
It is clear, however, that Ca^* influx through V.O.Cs 
and R.O.Cs is prevented by organic and inorganic antagonists 
to varying extents. The V.O.Cs are blocked readily by most 
compounds. Thus, responses to K"*" addition, which opens V.O.Cs 
to allow Ca^+ influx (Godfraind, I98I), are inhibited in the
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human mesenteric artery and vein (Mikkelsen e_t f 1979), 
the rabbit aorta (van Breemen e_k ai., I981) and the guinea-pig 
trachea (Advenier ejt , 1984). Ca^* influx through R.O.Cs, 
on the other hand, although prevented by the inorganic 
antagonists, is relatively resistant to the organic compounds 
(Flaim et al., I985; Oriowo, 1984). The inorganic agents are 
thought to simply 'plug' Ca^* channels in a competitive manner 
(Schramm & Towart, I985). They prevent Ca^ "*" influx, not only 
through V.O.Cs and R.O.Cs, but also through channels formed 
by Ca^*-ionophores (Snyder & Reynolds, 1985)* In contrast, 
the organic antagonists have a more complex mechanism of action. 
Ca^^ channel blockade through V.O.Cs by either verapamil,
D 600 or nifedipine increases with increasing depolarization 
and frequency of stimulation. They do not, however, slow 
activation of the channels (Lee & Tsien, I983; Trautwein, 1985)» 
The V.O.Cs may exist in different forms; resting (closed but 
available for activation), open (Ca^"^-conducting) and inactive 
(closed and unavailable for activation) states. Organic 
antagonists block either open or inactive states (Janis & 
Scriabine, I983; Lee & Tsien, 1983)»
The site and mechanism of action of organic Ca^ "*" channel 
antagonists has also been clarified by radioligand binding 
studies. These have emphasised the existence of binding sites 
associated with Ca^ "*" channels. The binding sites are located 
in the plasma membranes of, for example, the heart (Glossmann 
et al. , 1982), ileum (Bolger e;t , 1983) and aorta (Godfraind,
1981). They are, most likely, proteins associated with 
phospholipids; they are denatured by heat and sensitive to
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the proteolytic enzyme, trypsin and to phospholipases A and 
C (Glossmann et al., 1982). It is now clear that several 
different binding sites exist for the organic Ca^^ channel 
antagonists (Schramm & Towart, I985). Thus, for example, 
verapamil and its derivatives bind at a site at the 'inner 
mouth' of the Ca^ '*’ channel; quaternary compounds are effective 
only on the inside of the cell (Hescheler ^  ^ .  , I982).
On the other hand, dihydropyridines are thought to bind at a 
site at the 'outer mouth' of the channel (Glossmann ^  al.,
1982). For each organic compound, the binding is consistent 
with an action at a specific site; it is saturable, rapid, 
reversible and stereoselective (Janis & Scriabine, 1983)»
In addition to Ca^ "*" channel blockade, the antagonists 
have an affinity for blocking both, other channels and receptors 
at the plasma membrane. These include Na^ (Bayer e_t a l.  , 1975) 
and K'*’ channels (Kass, I982), together with a^-adrenergic 
(Galzin & Langer, I983), muscarinic (Fairhurst _e_t aT. , 1980) 
and serotoninergic receptors (Affolter et al., 1985)* The 
extent of these actions varies with each compound, but, in 
the main, only occurs with high concentrations, at which 
presumably, the drugs lose their selectivity for the Ca^* channels 
The antagonists may also have actions within the cell.
Indeed, one group of compounds, the methylenedioxyindenes, 
appear to exert their effects primarily by inhibiting Ca^* 
mobilization from the endoplasmic reticulum with little 
contribution being made by Ca channel blockade (Rahwan, 1985)» 
For the majority of agents, however, intracellular mechanisms
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appear to be less important. Generally, higher concentrations 
are required than those at which Ca^^ influx is inhibited. 
Notwithstanding, however, it is evident that the organic 
compounds can interact with the contractile proteins. Thus, 
in cardiac muscle, experiments with aequorin, a protein, which 
on combination with Ca"^ emits light (the 'Ca^^ signal'), 
have shown that the degree of tension for the same amount of 
' Ca^ "*" signal ' is smaller in the presence of the antagonists, 
than in their absence (Morgan e_t aT. , 1983)» Also, Ca^^- 
induced contractions of the guinea-pig taenia coli, treated 
with detergents to disrupt the plasma membrane, are inhibited 
by cinnarizine, fendiline, flunarizine and pimozide (Spedding,
1983)* An inhibitory interaction with calmodulin may be 
involved (BostrdJm et al. , I98I; Johnson, 1983)» Indeed, 
calmodulin-dependent phosphodiesterase activity is inhibited 
by both verapamil and nifedipine (Epstein aT., I982).
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AIMS OF THE THESIS
Interest in Ca^ '*’ channel antagonists has stemmed largely 
from their ability to prevent, postjunctionally, Ca^* influx 
into smooth and cardiac muscle and from their resulting benefits 
in the treatment of cardiac dysrrhythmias, hypertension and 
angina pectoris. There is, however, no a priori reason why 
interest should be restricted to their activity at postjunctional 
sites, since a physiological role for Ca^^ prejunctionally in 
transmitter release and in the AP of some nerves, is now 
established. Indeed, that Ca^ "*" entry is required for the 
release of all neurotransmitters, suggests that Ca^ "*" channel 
antagonists could provide an important pharmacological and, 
in consequence, clinically-useful means of controlling 
neuromuscular transmission in both smooth and cardiac muscle.
To date, the few investigations of such prejunctional 
activity, which have been carried out, have been fragmentary 
and the resulting effects attributed to the compounds, equivocal. 
The opportunity to contribute to this potentially important 
aspect of the activity of the antagonists was sufficiently 
challenging to prompt the present work. This thesis, therefore, 
represents attempts made to examine, systematically and in 
detail, the prejunctional effects of a number of organic and 
inorganic Ca^* channel antagonists. To do this, the release, 
of both excitatory and inhibitory neurotransmitters in tissues 
receiving different types of innervation, was measured djo. vitro, 
both directly, by collecting the overflow of radiolabelled 
transmitter and indirectly, by recording, with intracellular
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microelectrodes, junction potentials in smooth muscle. As 
interference with nerve AP conduction influences transmitter 
release, neuronal activity was also measured. This was achieved 
extracellularly with a suction electrode. The relevance of 
any prejunctional actions produced by the compounds was assessed 
by evaluating, in parallel, their effects, postjunctionally 
and in vivo.
-  4 l  -
CHAPTER 2; METHODS
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The methods were designed to allow investigation of 
the actions, especially at prejunctional sites, of a number 
of Ca^ '*’ channel antagonists. Prejunctional activity was 
examined by measurement of:-
(a) AP conduction along autonomic nerves. Interference with 
this process would have profound effects on both transmitter 
release and effector activity.
(b) neurotransmitter release from autonomic nerve terminals. 
This was done by studying drug-induced changes on the overflow 
of radiolabelled transmitter and on evoked junction potentials 
in smooth muscle (Burnstock & Holman, I961), which represent 
the initial membrane response of the muscle to transmitter.
The choice of preparation was governed by several factors. 
In studying prejunctional activity, a preparation with a 
readily accessible extrinsic nerve, suitable for AP conduction 
measurement, was required. It was also desirable that the 
neurally-released transmitter(s) in the preparation should 
have been identified and their responses, characterised.
Several such preparations were considered, e.g. the 
guinea-pig, mouse and rat vas deferens (for review, see 
Sjüstrand, I98I), guinea-pig urinary bladder (Langley & 
Anderson, I895), cat spleen (Gillespie & Kirpekar, I963) 
and rat anococcygeus (Gillespie, 1972). Of these, two were 
chosen: the guinea-pig vas deferens and the rat anococcygeus.
Each preparation was appropriate for the measurement of AP 
conduction, receiving a dense innervation by readily accessible 
extrinsic nerves. The guinea-pig vas deferens is innervated
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by excitatory sympathetic nerves. Although termed 'short 
adrenergic neurones' (SjOstrand, I965), because of the close 
proximity of their cell bodies to the muscle, these nerves 
are sufficiently long to allow measurement of AP conduction 
in response to both pre— and postganglionic stimulation 
(Perry, I967). Indeed the suitability of this tissue for AP 
conduction measurement has been demonstrated both vitro 
and vivo (Perry, I967).
The rat anococcygeus is innervated by separate 
extrinsic excitatory sympathetic and inhibitory non-adrenergic, 
non-cholinergic (nANC) nerves (Gibson & Gillespie, 1973), 
which, being relatively long, facilitate measurement of AP 
conduction. The dual innervation in this tissue suggested 
that an investigation of drug effects on AP conduction in 
each type of nerve was feasible.
The suitability of the guinea-pig vas deferens and rat 
anococcygeus for the measurement of transmitter release has 
also been established. The sympathetic nerves to the guinea- 
pig vas deferens are thought to release two transmitters - 
noradrenaline and adenosine 3'—triphosphate (ATP, Burnstock 
& Sneddon, 1984; Sneddon & Westfall, 1984) and the tissue is 
suitable for analysing, radiochemically, the release of both 
substances (Alberts e_fc al. , 1981; Westfall e_t al. , 1978). 
Transmitter release can also be measured by recording the 
e.j.ps in the smooth muscle of the guinea-pig vas deferens 
(Burnstock & Holman, I961). In the rat anococcygeus, 
noradrenaline, released from the sympathetic nerves, is measured
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readily by analysis of the large evoked e.j.ps in this 
tissue (Creed et al., 1975)* However, the rat anococcygeus 
is not so suitable for studying the effects of drugs on the 
release of the other, as yet unidentified, NANG transmitter, 
because the evoked i.j.ps are small and even insignificant 
(Creed et al., 1975)* To overcome this problem, a preparation 
was sought, in which NANC-mediated i.j.ps were large and 
measurable. The guinea-pig internal anal sphincter (i.a.s.), 
previously shown in this laboratory to exhibit large i.j.ps 
in response to NANO nerve stimulation (him & Muir, 1985), was 
chosen. The NANG transmitter in the guinea-pig i.a.s. has 
been suggested (him & Muir, I986), on the basis of results 
from intracellular electrical studies, to be ATP or a related 
nucleotide. It was hoped that this could be determined by 
radiochemical analysis. A disadvantage in using the guinea- 
pig i.a.s. was that the intrinsic nature of its NANG innervation 
(Costa & Furness, 1973) would not allow measurement of AP 
conduction.
The postjunctional actions of the Ga^* channel antagonists 
were also analysed by isometric monitoring of the mechanical 
activity of the tissues under investigation. This allowed a 
direct comparison to be made of the pre— and postjunctional 
actions of Ga^* channel antagonists.
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MORPHOLOGY AND INNERVATION OF TISSUES USED
(i ) Guinea-pig vas deferens
The vas deferens is responsible for the transport of 
spermatozoa and seminal fluid from the epididymis of the 
testis to the seminal vesicle duct near the prostate gland.
It comprises three smooth muscle layers: an outer and inner
longitudinal, which surround a circular layer. The smooth 
muscle cells are surrounded by connective tissue and overlap 
in an interweaving fashion (Merrillees, I968).
The innervation of the guinea-pig vas deferens has been 
described extensively (Merrillees, I968; Sjëstrand, I965» I98I). 
The tissue receives principally an excitatory sympathetic 
innervation by the hypogastric nerves, which originate at the 
T9-T10 level of the spinal cord and run to the inferior 
mesenteric ganglion. The hypogastric nerves, containing mainly 
preganglionic sympathetic fibres, pass from the inferior 
mesenteric ganglion to a plexus of ganglia located within 1 cm 
of the prostatic end of the vas deferens. From this plexus, 
postganglionic, mainly non—myelinated sympathetic nerve fibres, 
run first to the prostatic and then towards the epididymal 
end, sending off radial branches into the muscle.
The guinea-pig vas deferens also receives a parasympathetic 
cholinergic innervation (SjOstrand, I981). Most parasympathetic 
axons innervate the circular muscle layer and a few, the 
external longitudinal layer. The function of the parasympathetic 
nerves is unclear. They may provide an excitatory innervation 
or modify the sympathetic neurotransmission (Sjüstrand, I98I).
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(ii) Rat anococcygeus
The anococcygeus is a paired smooth muscle, suggested, 
as a consequence of its close proximity to the terminal colon, 
to be involved in the defalcation reflex (McGrath, 1973).
The tissue consists of parallel bundles of longitudinal smooth 
muscle fibres, arising from a tendinous origin attached to 
coccygeal vertebrae 1 and 2. Each muscle runs caudally, first 
behind the colon and then passes ventrally around either side 
of the terminal colon to fuse and so form a 'ventral bar' 
(Gillespie, 1972).
The rat anococcygeus receives both an excitatory (from 
postganglionic sympathetic adrenergic nerves, Gillespie, 1972) 
and an inhibitory (NANG) innervation, the transmitter of which 
is unknown. The sympathetic and NANG nerve fibres are believed 
to be separate (Gibson & Gillespie, 1973), and have a different 
spinal origin (TIG to L3 and L5 to S2 respectively). Two 
extrinsic nerve bundles, containing both excitatory and 
inhibitory fibres and originating from the posterior scrotal 
division of the perineal nerve and the external spermatic 
division of the genito—femoral nerve (Gillespie & Ldllmann— 
Rauch, 1974), run towards the anal end of the anococcygeus.
The nerves divide as they approach the muscle to form a nerve 
network on its lateral surface (McKirdy & Muir, 1978).
(iii) Guinea-pig internal anal sphincter
The internal anal sphincter (i.a.s.), which is involved 
in defaecation, coincides in the guinea-pig with a thickening 
(approximately 3 nim long and 3 nim broad) of the rectum wall
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(Fig. 4a). The sphincter consists of a band of circular 
smooth muscle fibres, more densely arranged than elsewhere 
in the rectum wall (Fig. 4b).
Of the two muscle layers of the rectum, the outer, 
longitudinal muscle extends over the inner, circular, 
sphincteric area. Each layer terminates 3-10 mm short of 
the anal margin and is separated from the skin by a band of 
largely connective tissue with a few circular smooth muscle 
fibres. The term 'internal anal sphincter' (i.a.s.) in this 
thesis denotes the circular muscle free from the longitudinal 
layer.
The i.a.s. is innervated by discrete excitatory sympathetic 
adrenergic and inhibitory NANG nerves (Gosta & Furness, 1973)* 
The sympathetic and NANG nerves enter the sphincteric muscle 
from the pelvic plexuses within the rectum wall. Extrinsic 
sympathetic nerves also enter the i.a.s. in the pudendal nerves 
which originate at the L6 and SI level of the spinal cord.
The longitudinal muscle, extending over the sphincteric area, 
receives a parasympathetic excitatory cholinergic innervation, 
the nerves of which also originate in the pelvic plexuses.
DISSECTION OF TISSUES
Adult male Duncan-Hartley guinea-pigs (300-1000g) and 
Wistar rats (l30-330g) were killed by cervical dislocation or 
stunning and then bled. Following a midline incision in the 
abdomen, the peritoneal cavity and its contents were exposed 
and the gastrointestinal tract displaced. During each
rectal wall mucosa
sphincteric
area
- ^
anus connective
tissue
10mm
Fig. 4 ; Diagrammatic indication of the position of the 
guinea-pig internal anal sphincter (magnification x 5). In 
this stretched preparation, the approximate location of the 
sphincter is indicated by a slight swelling of the rectum wall
(a). In b ., a longitudinal incision in the rectum has been 
made and the mucosa and submucosa removed. The sphincter can 
be identified as a band of circular smooth muscle in which 
the fibres are more densely arranged than elsewhere in the 
rectum wall. The sphincter is easily differentiated from 
the connective tissue adjacent to the anus.
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dissection, tissues were kept moist with Krebs solution (see 
later for formula), continuously bubbled with 95% 0^ and 5% CO^
(pH — 7• k ) ,
(i) Guinea-pig vas deferens
The testes were pushed into the peritoneal cavity and one 
vas deferens was freed at the prostatic end. Following separation 
from the testis, the vas deferens, together with its attached 
connective tissue, was transferred to a beaker of Krebs solution, 
bubbled with 95% 0^ and 5% CO^ at room temperature, until used 
as described below.
(ii) Rat anococcygeus
Following removal of vasa deferentia and seminal vesicles, 
the pubic symphysis was split and the bladder and urethra, 
discarded. The colon, ligated and cut at the level of the 
pelvic brim, was pulled forward and the connective tissue 
behind it, removed until the two anococcygeus muscles were 
visibleo Both muscles were ligated at their tendinous points 
of attachment to the coccygeal vertebrae and at the 'ventral 
bar'. Each anococcygeus, together with the surrounding 
connective tissue which contained the extrinsic nerves, was 
then transferred to a beaker of oxygenated Krebs, until used.
(iii) Guinea-pig internal anal sphincter
Following splitting of the pubic symphysis, a segment 
of the rectum, including the anal region, was transferred 
to a Sylgard (Dow Corning)-coated petri dish containing Krebs 
solution, bubbled with 95% 0^ and 5% (pH - 7»^)« The
rectum was pinned out and the skeletal muscle and connective 
tissue forming the external anal sphincter, removed. A
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longitudinal incision in the ventral wall of the rectum 
(approximately 2 cm in length) was made cranially from 
the anus. The mucosa and submucosa were then removed and 
the i.a.s. identified under a dissection microscope as a 
dense band of circular muscle (Fig. 4b). A horizontal strip 
(1 cm long and 0.2 cm broad, unstretched) of sphincter with 
attached longitudinal layer was dissected out. The longitudinal 
muscle layer was then carefully removed under the microscope.
MEASUREMENT OF ACTION POTENTIAL CONDUCTION IN AUTONOMIC NERVES
APPARATUS
(i) Organ bath
This was the same as that used for intracellular electrical 
studies (Fig. 9)* It consisted of a trough (4 cm x 1.5 cm x 
1 cm) cut from a perspex block (IO.3 cm x 6.3 cm x 2 cm). To 
minimize mechanical vibrations, the bath was bolted to two 
non-conducting pillars of Bakelite, which were fastened to a 
steel plate (200 kg) on a table mounted on Muffelite (K-I30) 
anti-vibration dampers. The bath (4 ml capacity) was perfused 
continuously (6 ml min ^ ) via two inlets (0.2 cm internal 
diameter) with Krebs solution (36 - 0.3°C), held in small 
diameter (0 .I3 cm internal diameter) polythene tubing. This 
tubing was surrounded, in turn, by an outer polythene tube 
of larger diameter (l cm internal diameter) containing liquid 
paraffin at 40 - 0.1°C, pumped from a Tempette (TE?) pump.
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Drugs were either perfused with the Krebs solution or added 
directly to the bath by syringe.
(ii) Suction electrode
Nerve activity was recorded extracellularly by a suction 
electrode (Figs. 3 and 6). This consisted of a glass micro- 
electrode, filled with Krebs solution, the shaft of which was 
connected by polythene tubing (0 .I3 cm internal diameter) to 
the needle of a glass syringe (l ml), filled with liquid 
paraffin. Changes in pressure at the microelectrode tip were 
induced when the plunger of the syringe, surrounded by a steel 
spring, was moved by rotation of a screw, thus allowing a 
nerve bundle to be sucked into the microelectrode tip. A 
silver wire inside the microelectrode served as the recording 
electrode and a Ag/AgCl pellet in the organ bath, as the 
indifferent electrode. Electrical signals were passed from 
the silver wire in the suction electrode to an A.C. preamplifier 
(Neurolog NL103)» filtered (low and high frequency cutoffs - 
100 and 1000 Hz respectively (Neurolog NL II3)) and displayed 
on a storage oscilloscope (Tektronix 3IO 3N), from which 
signals were recorded on an F.M. tape recorder (Racal 4DS).
RECORDING FROM GUINEA-PIG HYPOGASTRIC NERVES IN VITRO
A pair of bipolar Ag/AgCl ring electrodes (0.3 cm diameter, 
0.2 cm separation), placed midway along the tissue (Fig. 7)f 
allowed postganglionic stimulation (0.3 Hz, O.O3 - 0.3 ms, 
supra— or submaximal voltage) of the hypogastric nerves to 
be carried out. Both ends of the preparation were pinned, at
Fig. 5: Suction electrode for extracellular measurement of
nerve AP conduction. A silver wire (w) was connected 
electrically via a Limo socket (LS)> embedded in perspex, 
to the recording circuitry (Fig. 7)« A glass microelectrode 
(m ) was placed over the silver wire and connected via polythene 
tubing (PT), filled with liquid paraffin, to the remainder 
of the apparatus (Fig. 6).
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Fig. 6; Suction electrode for extracellular measurement of 
nerve AP conduction. Changes in pressure at the microelectrode 
tip (Fig. 3) were induced by movement of the plunger (p) of a 
glass syringe (GS)> in either direction, by means of a perspex 
screw (Sc) and a steel spring (s) placed around the plunger.
The syringe, filled with liquid paraffin, was connected to 
the remainder of the suction electrode (Fig. 5) hy polythene 
tubing (PT).
F ilte rs » Oscilloscope
A.C. preamplifier
f
Tape recorder
Class
microelectrodeA g wire
Stimulator
Prostatic
end
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end
Ag/AgCl ring 
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Hypogastric
nerve
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Connective
tissue
Fig. 7 : Extracellular recording of AP conduction ini vitro >
in a small bundle of guinea-pig hypogastric nerve fibres, 
using a suction electrode. The central cut end of a small 
nerve branch at the epididymal end of the vas deferens was 
sucked into the broken tip of a glass microelectrode, filled 
with Krebs solution. APs were recorded following stimulation 
of the main nerve trunk with a pair of Ag/AgCl ring electrodes 
placed midway along the tissue. Electrical signals from the 
silver recording electrode were amplified, filtered and 
displayed on an oscilloscope, from which they were recorded 
on tape.
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resting length, to the Sylgard base of the bath. The 
electrodes were connected to a square pulse stimulator 
(Devices Mk.IIl), which was triggered by a pulse generator 
(Devices 2^21), gated in turn by a Digitimer.
To gain access to the small hypogastric nerves, a 
longitudinal incision was made through the connective tissue 
overlying the muscle. The surrounding connective tissue was 
pinned back and laterally stretched to allow the nerves to be 
visualized microscopically. A small hypogastric nerve bundle 
(3O—100 ]im in diameter) was cut near its point of entry into 
the epididymal end of the tissue. The glass microelectrode 
tip was broken under microscopic control and its diameter 
matched approximately to that of an available nerve bundle.
The central cut end of the nerve bundle was drawn into the 
microelectrode tip by applying suction, to allow measurement 
of stimulation-evoked APs to be made.
RECORDING FROM GUINEA-PIG HYPOGASTRIC NERVES IM VIVO
The ready accessibility of the vas deferens and its 
extrinsic nerves made this investigation feasible (Ferry, 1967). 
Adult male Duncan-Hartley guinea-pigs (400-800g), anaesthetised 
with urethane (l.?g kg~^i.p.)» were placed, ventral side 
uppermost, on a thermostatically—controlled heated (37 — 0.1 C) 
blanket (C.F. Palmer 8I85). The trachea was cannulated to 
allow artificial respiration, the right jugular vein for i.v. 
administration of drugs and the left carotid artery for 
measurement of blood pressure and heart rate. The arterial
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cannula, containing heparinized saline (90 I.U. ml ^ of 0 .9%
NaCl in distilled water) to prevent coagulation, was connected 
via a blood pressure transducer (Gould P23ID), to a pen 
recorder (Harvard Universal Oscillograph).
The abdomen was opened by a midline incision and the 
overlying skin sutured to a metal ring (4.6 cm internal diameter), 
clamped above the abdomen (Fig. 8). The gastrointestinal tract 
was displaced and the peritoneal cavity filled with Krebs 
solution. The temperature of the animal was monitored rectally 
by a probe connected to the heated blanket and maintained at 
37 - 1°C.
On occasion, drugs were added by close-arterial injection 
via the left external iliac artery, cannulated retrogradely, 
peripheral to its junction with the internal iliac artery.
The patency of this route was confirmed by injection of 
indian ink.
For convenience, pre- rather than postganglionic stimulation 
(0.2 Hz, 0.1 - 0.3 ms, supramaximal voltage) of the hypogastric 
nerves, approximately 2 cm from the vas deferens, was carried 
out using a pair of platinum hook electrodes. The electrodes 
were connected to an isolated stimulator (Digitimer DS2) 
and this, in turn, to a frequency generator (Scientific and 
Research Instruments 6030). The left vas deferens was then 
pinned on to a piece of silicone rubber, placed inside the 
peritoneal cavity. The subsequent dissection and recording 
of APs were carried out in a manner similar to that described 
previously for the in vitro investigation. APs were passed 
to a preamplifier and filtered (low and high frequency cutoffs - 
80 and 230 Hz respectively (Tektronix RM 122)). Signals
stim ulation Electrodes
Earth Electrode
Suction
Cotton
Vas Deferens
K rebs-filled  
Peritoneal Cavity
Drug addition 
( i.a .) Temperature
Probe
Fig. 8 ; Extracellular recording of AP conduction vivo in 
a small bundle of hypogastric nerve fibres in the anaesthetised 
guinea-pig (I.7 gkg ^ urethane i.p.). Following a midline 
incision, the abdominal wall was sutured to a metal ring clamped 
above the animal, the gastrointestinal tract placed under 
moistened cotton gauze and the peritoneal cavity filled with 
Krebs solution. The temperature of the animal was monitored
rectally with a probe and maintained at 37 - 1°C. A pair of
y
platinum hook electrodes was placed under both hypogastric 
nerve trunks, some 2 cm from the vas deferens, to provide 
preganglionic stimulation. The vas deferens was pinned to a 
piece of silicone rubber and APs recorded from the small 
central cut end of a nerve bundle at the epididymal end of 
the tissue, using a suction electrode. The earth electrode 
consisted of a metal plate placed inside the peritoneal cavity. 
Cannulation of the external iliac artery allowed close-arterial 
drug addition to the vas deferens. Drugs were also given i.v. 
by cannulation of the jugular vein (not shown).
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were displayed on a storage oscilloscope (Telequipment DM64) 
and recorded permanently on tape (Racal 4DS). An image 
analyser and computer (Hewlett Packard)were used to determine 
the latency, duration and area of the AP discharges.
RECORDING FROM RAT ANOCOCCYGEUS NERVES IN VITRO
The anococcygeus was pinned to the Sylgard base of the 
organ bath and the attached genito-femoral and perineal branches 
of the pudendal nerve gently pulled through a separate pair 
of bipolar Ag/AgCl ring electrodes (0.2 cm diameter, 0.2 cm 
separation) for stimulation (single pulses, 0.1 - 0.5 ms, 
supramaximal voltage). The electrodes were connected to a 
stimulator (Devices Mk III), triggered by a pulse generator 
(Devices 2521) and Digitimer. Stimulation-evoked APs were 
recorded as already described.
In order to record APs from the NANG nerves of the 
anococcygeus, the sympathetic nerves were destroyed by pre­
treating rats with reserpine (l mg kg ^ i.p. daily for 3 days) 
and 6-hydroxydopamine (15O and 250 mg kg  ^ i.p. for the 
following 2 days). The effectiveness of the pretreatment was 
assessed by the Falck histofluorescence technique (modified 
by Gillespie & Kirpekar, I966). In this technique, catecholamines 
in sympathetic nerves are condensed by exposure to formaldehyde 
vapour, producing fluorophores of isoquinoline which absorb 
light at 4lO nm and emit light at 480 nm. Tissues were 
frozen in isopentane, itself cooled by liquid nitrogen, to 
remove any moisture and so avoid tissue damage on freezing.
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and then transferred to a freeze-drier (Pearse Speedivac) 
under a partial vacuum (O.Ol torr) at -4o°C for 24 h. Muscles 
were exposed thereafter to paraformaldehyde at 80°C in an oven 
for 1 h. Transverse sections (6 p, thick) were cut, mounted 
in liquid paraffin and examined under u.v. light using a 
Leitz Orthoplan microscope with a BG 12 narrow band filter 
for excitation and a Zeiss No.4? barrier filter. Photographs 
were taken with a Leitz Orthomat camera.
INTRACELLULAR RECORDING OF SMOOTH MUSCLE ACTIVITY
In these experiments, simultaneous electrical and 
mechanical recordings were made from the guinea-pig vas 
deferens and i.a.s. and the rat anococcygeus. In each tissue, 
evoked junction potentials were used to assess the effects of 
Ca^* channel antagonists on transmitter release.
Each tissue was pinned to the Sylgard base of a horizontal 
perspex organ bath (Fig. 9)> the characteristics of which have 
been previously described. In the case of the vas deferens 
and i.a.s., field stimulation (single pulses and 5~20 pulses
at 1-20 Hz, 0.1 - 0.5 ms, supramaximal voltage) was provided
by a pair of bipolar Ag/AgCl ring electrodes (0.3 cm diameter, 
0.2 cm separation), placed midway along each tissue. The 
genito-femoral and perineal branches of the pudendal nerve, 
which innervate the anococcygeus, were stimulated (5 pulses 
at 5-20 Hz, 0.1 - 0.5 ms, supramaximal voltage) simultaneously
by means of two pairs of bipolar Ag/AgCl ring electrodes
(0.2 cm diameter, 0.2 cm separation). The anococcygeus was 
stimulated via its extrinsic innervation, rather than by field
■ I^s QUTIFT
Fig. 9 : Organ bath for combined intracellular electrical
and mechanical recording. The bath comprised a central 
trough (4 cm x 1.5 cm x 1 cm) cut from a perspex block. The 
block was drilled to accept stainless steel inlet tubes 
(0.2 cm internal diameter) for Krebs solution and outlets for 
drainage. The body of the muscle was pinned to the Sylgard 
base of the trough and intracellular recordings made from the 
pinned area. One free end was tied by thread to an isometric 
transducer. Field stimulation by an isolated stimulator was 
effected via Ag/AgCl ring electrodes (+V and -V). The bath 
was perfused with oxygenated pre-heated Krebs solution (36 - 
0.5°0); supplied via two inlets by gravity flow. The polythene 
tubing (0.2 cm internal diameter) containing the Krebs solution 
was surrounded by an outer tube (l.O cm internal diameter) 
containing liquid paraffin (at 40 - 0.1°C), pumped from a 
thermostatically-controlled Tempette pump.
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stimulation, to allow simultaneous measurement of nerve AP 
conduction (by suction electrode), e.j.ps and mechanical 
responses to be made* The electrodes were connected to a 
square wave pulse stimulator (Devices Mk III) which was 
triggered by a pulse generator (Devices 2521) and gated by a 
Digitimer. The mechanical activity of each tissue was 
monitored: the i.a.s., vas deferens (prostatic end) and
anococcygeus (tendinous end) were each connected by thread 
to an isometric force-displacement transducer (Grass FT03c) 
under tension (ig).
Changes in membrane potential were recorded intracellularly 
using capillary glass microelectrodes (l5-40 MS ), filled 
with 3M KOI. Electrical measurements from the vas deferens 
and i.a.s. were made up to 0.4 cm from the stimulating 
electrodes. The microelectrode was connected to a unity gain 
high impedance (lO^^ S ) D.C. preamplifier (WPI M44a) via a 
Ag/AgCl half cell, attached to a probe, matched and calibrated 
for the amplifier used. The indifferent electrode was a 
Ag/AgCl pellet in the organ bath. Electrical signals, passed 
via the preamplifier, were displayed on one channel of a 
storage oscilloscope (Tektronix 5103^) and on a digital 
voltmeter (Fairchild M53). The mechanical responses measured 
by the transducer were displayed on the other channel of the 
oscilloscope. Electrical and mechanical measurements were 
amplified and recorded on a u.v. recorder (SE Oscillograph 
3006 and 6150) and stored on tape (Racal 4ds).
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CRITERIA FOR CELL PENETRATION
A cell was accepted for electrophysiological investigation 
provided the following criteria were satisfied;-
(a) the penetration was sharp and the membrane potential, 
stable, varying by not more than 2 mV.
(b) junction potentials were observed in response to nerve 
stimulation.
(c) the voltage measured prior to penetration was restored 
following withdrawal of the microelectrode.
RADIOLABELLED TRANSMITTER RELEASE
As an alternative means of measuring transmitter release, 
the transmitter pools of the nerves to the guinea-pig vas 
deferens and i.a.s. were labelled radiochemically and the 
overflow from each tissue analysed for radioactivity. In this 
investigation, the term 'overflow' is defined as the amount of 
neurotransmitter which escaped the uptake processes and was 
collected from the tissue.
Tissues were incubated in Krebs solution (37°C) containing 
either (a) -noradrenaline (25 )iCi ml ^ , 2 x 10 ^M
noradrenaline for 30 min) or (b) —adenosine (50 and
150 uCi ml” ,^ 1 and 3 x 10”^M adenosine for 1 h) and then rinsed 
with Krebs solution. Tissues were pulled gently through a 
pair of bipolar Ag/AgCl ring electrodes (0.3 cm diameter,
0.2 cm separation) located inside a heated (37 — 0.5 0 ) water 
jacket, and attached at one end to a hook on the electrode 
assembly (Fig. lO). The other end of each tissue (the
transducer
amplifier
pen
recorder transducer
wafer outlet
krebs
stimulator
tissue
water
inlet
A g / A g  Cl 
ring electrodes
water jacket
tempette
pump
krebs collection
Fig. 10; Apparatus for measuring H overflow. Each tissue, 
loaded with either [^h] -noradrenaline or [^nj -adenosine, was 
attached by thread to an isometric force-displacement transducer 
at one end and the other end passed through bipolar Ag/AgCl 
ring electrodes and securely anchored by thread to a hook on 
the electrode assembly. The tissue was located inside a heated 
glass water jacket (37 - 0.3°C) and superfused (l mlmin ^ ) 
with oxygenated Krebs solution. The polythene tubing (0.2 cm 
internal diameter) containing the Krebs solution was surrounded 
by an outer tube (l.O cm internal diameter) containing water 
at k2 - 0.5°C, circulated by a thermostatically-controlled pump.
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epididymal end, in the case of the vas deferens) was connected, 
under tension (ig), by thread to an isometric force-displacement 
transducer (Grass FT03C). The ring electrodes were connected 
to a stimulator (Grass SD9) for field stimulation. Drugs 
were added to the Krebs solution, which was pumped through 
polythene tubing (0.2 cm internal diameter) using a Watson— 
Marlow (Type 22) flow inducer. The tubing was surrounded by 
an outer jacket (1 cm internal diameter) containing water 
[k2 - 0.3°C) pumped by a Tempette (TE7) pump. The polythene 
tubing was positioned to allow superfusion of the preparation 
with Krebs solution (l ml min” ,^ 37°C). 2 min samples of
superfusate were collected in vials placed under the tissue.
Vasa incubated with [^hJ -noradrenaline (25 pCi ml ^ ) 
were superfused throughout each experiment with Krebs solution 
containing ascorbic acid (1.1 x 10 M) to inhibit catecholamine 
oxidation, desipramine (6 x 10 ^M) and normetanephrine 
(l X 10”-^ M) to inhibit neuronal and extraneuronal catecholamine 
uptake respectively and atropine (2.6 x 10 ^M) to block the 
cholinergic transmission which exists in this tissue (Sjëstrand, 
1981). Under these conditions, approximately 90% of the 
catecholamine in the tissue is believed to be noradrenaline 
(Alberts ejfc ^ .  , I98I). The effects of drugs on stimulation 
(60 pulses at 1-20 Hz, 0.5 ms, supramaximal voltage)-evoked 
overflow were examined 15 min after commencing drug super­
fusion.
It is believed (Westfall ^  » 1978) that in the guinea-
pig vas deferens, contraction of the muscle per se, contributes
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to the release of ATP. Accordingly, to prevent muscle 
contractions, vasa incubated with [^h] -adenosine (15O pCi ml~^) 
were superfused with a hypertonic Krebs solution containing 
sucrose (0.37M). Additionally, a, methylene adenosine 5 ’-
triphosphate (a, me ATP ) and prazosin (each 5 x 10 ^M) were
added to prevent the postjunctional effects of ATP and
noradrenaline respectively, which are released from the
sympathetic nerves (Burnstock & Sneddon, 1984). One tissue 
from each animal was superfused with the drug being studied, 
while the contralateral tissue served as control and both were 
stimulated simultaneously (400-2000 pulses at 20 Hz, 0.5 ms, 
supramaximal voltage), I5 min after commencing drug superfusion.
The guinea-pig i.a.s. incubated with [^h ] -adenosine
(50 pCi ml ^ ) was superfused with Krebs solution containing
atropine (l x 10 ^M) to inhibit cholinergic responses of any
residual longitudinal muscle and phentolamine and guanethidine
(each 1 X 10 ^M) to inhibit responses to, and release of,
noradrenaline respectively. Drug effects on stimulation
(200-900 pulses at 2-20 Hz, 0.5 ms, supramaximal voltage) - 
3
evoked H overflow were examined I5 min after commencing 
superfusion.
0.5 ml aliquots of the tissue superfusate were added to 
a scintillation mixture (lO ml) containing toluene: triton-X:
O
scintol-2 (12.33: 6.67: 1, v:v:v) and the amount of H measured 
with a scintillation counter (Packard 3390)' The amount of 
^H, in counts per minute (CPM), was corrected for the efficiency 
of the counter (approximately 30%) and expressed as disinte­
grations per minute (DPM), or as the fractional release of
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3
H, i.e. the overflow evoked by stimulation, as a fraction
3
of the total H in the tissue at that time. This was determined 
after dissolving the tissue at the end of the experiment in 
potassium hydroxide (0.5M) and counting an aliquot of the 
sample.
CHROMATOGRAPHIC IDENTIFICATION OF [^H -COMPOUNDS
The radioisotope experiments per se, measured the total
3
H and did not allow identification of the compounds into 
3
which the H was incorporated.
To do this, chromatographic techniques were used and the 
major metabolites of both noradrenaline and ATP (Norman et al., 
1974; Pull & Mcllwain, 1972; Tarlov & Langer, 1971)> separated 
and identified. Identification of the [^h ] -compounds in the 
overflow allowed a further analysis of drug and nerve-induced 
effects on release to be made.
The guinea-pig vas deferens and i.a.s. were incubated 
with [ h^ ] -noradrenaline and [^ h ] -adenosine respectively, as 
before, and samples of superfusate collected for chromatography.
(i) Separation and identification of ^HI -noradrenaline and
its metabolites 
The ^H in the superfusate from vasa incubated with [ h^ ] - 
noradrenaline was separated into noradrenaline and its principal 
metabolites (Tarlov & Langer, 1971); 3,4-dihydroxyphenylglycol 
(DOPEG), 4-hydroxy 3-methoxymandelic acid (VMA) and 4-hydroxy 
3-methoxyphenylglycol (MOPEG), 3,4-dihydroxymandelic acid (DOMA) 
and normetanephrine (NMN). The method of separation (Fig. 11) 
was that of Graefe ejk (1973); Nicol (l975) and Tillman
(1977).
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+  Wash 
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2ml FLO
VMA/MOPEG
li]
3-Sml 0-2MCHJ:OOH 
Uml O-SMCHJlOOH
2mt aliquot
DOWEX SOW X  A 
iO'Sml.pHhZ)
2ml ÔMHCl 'EtOH 
[1-1]
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2mlHJ3
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Un]
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I
Discard
(iv)
3ml3MHCl
f/7)
3mlO-2MHCl
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Fig. 11 ; Flow diagram of the chromatographic separation of 
-noradrenaline from its metabolites. 2 ml samples (pH
8.2 - 8.4) were applied to a column containing alumina (Al^O^). 
The compounds in the effluent and washings from this column 
were separated by another column, containing Dowex 50W x 4 
resin. 4-Hydroxy 3-methoxymandelic acid (VMA) and 4-hydroxy 
3-methoxyphenylglycol (MOPEG) were present in the effluent 
and washing and normetanephrine (NMN) in the eluate, following 
addition of HCl:EtOH. Noradrenaline (NA) and 3;4-dihydroxy- 
phenylglycol (DOPEG) were eluted from the alumina-containing 
column with GH^COOH (i) and 3,4-dihydroxymandelic acid (DOMA), 
with HCl (ii). The NA/DOPEG fraction was separated by another 
column, filled with Dowex 50W x 4 resin, the effluent and 
washing from which contained DOPEG. Following further washing 
with H^O (iii), NA was eluted with HCl (iv).
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The chromatographic procedure involved passing the 
superfusate from the guinea-pig vas deferens through three 
columns; one containing alumina (Sigma) and two, Dowex 5OV x 4 
(200—400 mesh. Sigma), a strong cation exchange resin. Each 
column consisted of a shortened glass Pasteur pipette stoppered 
with cotton wool (length 10 cm, diameter O.5 cm to 0.2 cm at 
the tip). The alumina and Dowex resin were prepared prior to 
use. Alumina (0.2 g), prepared by the method of Grout (1961), 
was added dry to columns and washed with sodium acetate (5 ml, 
0.2M, pH 8.2). Dowex resin was washed several times with 
NaOH (2M) containing ethylenediamine tetra-acetic acid (EDTA, 
O.O3M), at 50°C, until the supernatant was clear and then with 
distilled water, HCl (2M), distilled water again and finally 
stored in HCl (O.OIM). Dowex resin was added to columns as a 
slurry (0.5 ml) and then washed with distilled water.
Samples of superfusate (2 ml) were collected prior to, 
and following field stimulation (3OO pulses at 20 Hz, O .5 ms, 
supramaximal voltage), in vials placed on ice. Each sample 
was adjusted to pH 1-2 with perchloric acid (0.4m), which 
contained EDTA (3 x 10""^M) and sodium metabisulphite (5*3 x 10 ^M) 
to precipitate protein and minimize catecholamine breakdown. 
Unlabelled noradrenaline, DOPEG, VMA, MOPEG, DOMA and NMN 
(each 10 p,l, 1 mg ml”^) were then added as carriers for the 
much smaller amounts of labelled compounds.
The pH of each sample of superfusate was adjusted to
8.2 - 8.4 with Tris buffer (0 .5M) and added to the column 
containing alumina. The column was then washed with sodium
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acetate (l ml, 0.2M) and distilled water (2 ml). VMA, MOPEG 
and NMN, which are not retained by the alumina, were collected 
in the effluent and washing. To separate VMA and MOPEG from 
NMN, an aliquot (3 ml) of the effluent and washing from the 
alumina and distilled water (2 ml) were added to the first 
of the two columns filled with Dowex resin. VMA and MOPEG 
passed through the column, while NMN, retained by the Dowex 
resin, was eluted with HCl-ethanol (2 ml, 6m , 1:1 v/v).
The compounds retained by the alumina were eluted; 
noradrenaline and DOPEG with acetic acid (3.5 ml, 0.2M and 
4 ml, O.3M) and DOMA with HCl (3 ml, 0.2M). Separation of 
noradrenaline from DOPEG was achieved using the remaining 
column filled with Dowex resin. An aliquot (2 ml) of the 
combined noradrenaline and DOPEG fraction, followed by distilled 
water (2 ml), was added to the column. DOPEG, which is not 
retained by the Dowex resin, passed straight through the column. 
After further washing with distilled water (2 ml), to ensure 
complete removal of DOPEG, noradrenaline, bound to the Dowex 
resin, was eluted with HCl (3 ml, 3M).
Each separated fraction (0.5 ml) was added to scintillant 
(10 ml, composition as before) and the ^H counted. The amount 
of radioactivity in each of the metabolite samples, compared 
to that in the sample before separation, gave an indication 
of the recovery and efficiency of each column. The mean 
recovery for the column filled with alumina was 9^.8 — 2.5%
(n = 45) and for the two columns with Dowex resin, 97.1 - 3.3% 
and 86.4 - 2.3% (n = 45).
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(ii) Separation and identification of 3h -ATP and its
metabolites
3
The H in the superfusate from the i.a.s., together 
with the total amount retained by nerves and muscle, following 
incubation with [^h ] -adenosine, was separated into ATP 
and its major breakdown products (Norman e_t , 1974), 
adenosine 5'—diphosphate (ADP), adenosine 5'—monophosphate 
(a m p ), hypoxanthine, cAMP and adenosine and inosine.
Samples of superfusate (5 ml) were collected prior to, 
and following field stimulation (2400 pulses at 20 Hz, 0.5 ms, 
supramaximal voltage) in vials placed on ice. The i.a.s. 
was then homogenised in perchloric acid (5 ml, 0.25M) to 
disrupt the cells and prevent enzyme activity. The cellular 
debris and proteins were then sedimented by centrifugation 
at 0°C (15300 rpm for 15 min) and the supernatant transferred 
to a vial placed on ice.
The technique used to separate and identify the [^h] - 
compounds was thin layer chromatography (TLC), as described 
by Norman e_t a^, (1974) and Pull & Mcllwain (1972). Identification
of compounds by TLC necessitates the use of a small sample 
volume. Preliminary studies, however, with a 50 pi aliquot 
of the superfusate from the i.a.s. revealed that the amount 
of ^H was insufficient to enable an accurate detection to be 
made. Accordingly, the radioactivity in each sample was 
concentrated prior to TLC separation (Tsuboi & Price, 1959)»
The [^nj -compounds in each sample of superfusate or tissue 
supernatant were adsorbed on to charcoal (5 mg) in perchloric
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acid (1.25 ml, IM, 4 C). After centrifugation (2000 rpm 
for 5 min), to sediment the charcoal and adsorbed material, 
the supernatant of each sample was discarded and the eluted 
by addition of pyridine (0.5 ml, 1 .26m), with occasional mixing 
for 2 h. The pyridine—charcoal mixture was then centrifuged 
and the resulting supernatant, which contained the [^h] - 
compounds, transferred to a small vial for the next step. A 
gentle stream of 0^—free was passed over the supernatant 
to evaporate the pyridine and leave a concentrated aqueous 
sample.
In preparation for TLC separation, methyl orange (2 pi, 
O.23M) was added to each concentrated sample. Perchloric 
acid (1M) was then added to adjust the pH to 3-4, at which 
value, methyl orange changed colour to red. Each sample (30 pi), 
together with standard solutions of ATP, ADP, AMP, hypoxanthine, 
cAMP, adenosine and inosine (lO pi, 1 mg ml ^ ), were spotted 
on to two silica gel-coated TLC glass plates (Merck 601^^^).
A different solvent system was used for each plate, allowing 
separation and identification of most of the [^h] -compounds 
present. cAMP, hypoxanthine and adenosine and inosine (R^ 
values 0.23; O.3I and 0.39 respectively), but not ATP, ADP or 
AMP, which remained at or near the origin, were separated with 
butan-l-ol: ethyl acetate : methanol : ammonia (7:4:3 :4, by vol.).
ATP, ADP and AMP (R^ values O.3O, 0.39 and O .53 respectively), 
but not the remaining compounds (R^ value O.63), were separated 
using isobutyl alcohol : amyl alcohol : ethoxy ethanol : ammonia: water 
(13:10:30:13:23, by vol.). Using both these solvent systems.
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adenosine and inosine had the same value and therefore 
could not be separated. Spots produced by the standards 
were located under u.v. light, outlined in pencil and the 
silica gel scraped and transferred to scintillation vials 
for counting.
RELEASE OF ATP IN THE GUINEA-PIG INTERNAL ANAL SPHINCTER
In addition to the radioisotope experiments, two further 
attempts were undertaken to determine if ATP is the NANC 
transmitter in the guinea-pig i.a.s. (him, I985; Lim & Muir,
1986).
The i.a.s. was superfused as before (Fig. 10) and samples 
of superfusate collected prior to, and following field 
stimulation (lOO-lOOO pulses at 10 and 20 Hz, 0.1 - O .3 ms, 
supramaximal voltage). The Krebs solution contained atropine 
(1 X 10 ^M) to inhibit cholinergic responses of residual 
longitudinal muscle and phentolamine and guanethidine (each 
1 X  10 ^M) to inhibit responses to, and release of, noradrenaline
/ —4 \respectively. Sodium vanadate (1 x 10 M), an ATPase inhibitor 
(Cantley e_t al. , 1977); was added to prevent the breakdown 
of ATP. Samples of superfusate were subjected to the following 
procedures.
(i) Analysis by thin layer chromatography
Trichloroacetic acid (3 ml, 1.2M) was added to each sample 
of superfusate (lO ml) to denature any enzymes present.
Following mixing and centrifugation (4000 rpm for 13 min),
4 volumes of water-saturated diethyl ether were added to the
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supernatant and the organic phase, containing the trichloro­
acetic acid, discarded. The aqueous phase, containing ATP 
and its metabolites, was then freeze-dried (Edwards Modulyo) 
and resuspended in distilled water (l ml). An aliquot (O.l ml) 
of each sample was spotted on a polyethyleneimine—cellulose- 
coated TLC plastic sheet (Merck 3579)* The solvent used was 
lithium chloride (1M). Spots were detected by u.v. light 
and identified by comparison to those produced by standard 
solutions of ATP and its metabolites (lO pi, 1 mg ml ^ ).
(ii) Luciferase-luciferin luminescence
The luciferase-luciferin luminescence technique is a 
sensitive means of assaying ATP (Strehler & Totter, 1932).
The principle behind this method is the interaction of ATP 
with synthetic luciferin and with luciferase extracted from 
firefly tails. This interaction emits luminescence which 
can be detected.
Luciferase-luciferin (O.l ml, 40 mg ml ^ ) was added to 
an aliquot (0.3 ml) of each sample of superfusate and the 
luminescence detected with a luminescence aggregometer 
(Chronolog Corporation), connected to a pen recorder (Linseis). 
The luminescence from samples of superfusate was compared to 
that produced by known concentrations of ATP, dissolved in 
Krebs solution.
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ANALYSIS OF RESULTS
Where appropriate, results were expressed as the mean - 
the standard error of mean (s.e. mean); n = number of 
observations. Student's t-tests were used to test for 
significance (p < O.O5) between means.
PHYSIOLOGICAL SOLUTIONS
The ionic composition of the Krebs physiological saline 
solution (Krebs & Henseleit, 1932), used throughout the 
investigation, was (x 10 ^M): NaCl 118.4, KCl 4.7, CaCl^ 2.7;
NaH^PO^ 1.1, MgCl^ 1.3; NaHCO^, 23.0 and (+)-glucose 11.0.
To prevent precipitation of insoluble cobalt salts when 
used in high concentrations (above 2 x 10 ^M), and to maintain 
isotonicity, tris buffer (2.3 x 10 ^M) and choline chloride 
(23.6 X  10 ^M) replaced NaH^PO^ and NaHCO^ in the Krebs solution. 
The modified Krebs solution itself was inactive, having no 
effect on nerve AP conduction in either the guinea-pig vas 
deferens or rat anococcygeus.
DRUGS
The following drugs were used: adenosine (Sigma), 2,3';8- 
[^h ] -adenosine (Amersham International, 40-60 Cimmol ^ ), 
adenosine 3',3'-cyclic monophosphate (cAMP, Sigma), adenosine 
3'-monophosphate (AMP, Sigma), adenosine 3 '-diphosphate (ADP, 
Sigma), adenosine 3'-triphosphate (ATP, Sigma), amlodipine 
maleate (Pfizer), (-)-ascorbic acid (Koch-Light), atropine 
sulphate (Sigma), choline chloride (Hopkin and Williams), 
cobaltous chloride (Koch-Light), cremophor EL (Sigma),
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desipramine hydrochloride (Ciba), (-)-3,4-dihydroxymandelic 
acid (DOMA, Sigma), (-)-3,4-dihydroxyphenylglycol (DOPEG,
Sigma), diltiazem hydrochloride (Sigma), dipyridamole (Sigma), 
ethylene diamine tetra-acetic acid (EDTA, Sigma), guanethidine 
sulphate (Ciba), heparin sodium (Evans), 6—hydroxydopamine 
hydrobromide (Sigma), (-)-4-hydroxy 3-methoxymandelic acid 
(VMA, Sigma), 4-hydroxy 3-methoxyphenylglycol (MOPEG, Sigma), 
hypoxanthine (Sigma), inosine (Sigma), lignocaine hydrochloride 
(Sigma), Tuciferase-Tuciferin (Sigma), a,P methylene adenosine 
5'-triphosphate (a,^ meATP, Sigma), methyl orange (Sigma), 
nicardipine hydrochloride (Sigma), nifedipine (Pfizer), (-)-?,8- 
-noradrenaline (Amersham International, 8-l4 Cimmol ^ ),
(-)-noradrenaline bitartrate (Koch-Light), (-)-normetanephrine 
hydrochloride (NMN, Sigma), paraformaldehyde (Hopkin and Williams) 
pentolinium tartrate (May & Baker), perchloric acid (Hopkin 
and Williams), phentolamine mesylate (Ciba), potassium hydroxide 
(Hopkin and Williams), (^)-prazosin hydrochloride (Pfizer), 
reserpine (Sigma), sodium metabisulphite (BDH), sodium nitro- 
prusside (BDH), sodium vanadate (Riedel-De Haën AG Seelze- 
Hannover), sucrose (Formachem), tetrodotoxin (TTX, Sigma), 
trichloroacetic acid (Koch-Light), tris (hydroxymethyl) 
aminomethane (Sigma), tris (hydroxymethyl) aminomethane 
hydrochloride (Sigma), urethane (Sigma), (-)-verapamil hydro­
chloride (Sigma). TTX and reserpine were expressed as the 
concentration of the base; other concentrations in the text 
refer to the salts. The solvents used, were all of analytical 
grade or better.
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With the following exceptions, drugs were dissolved in 
0 .9% NaCl in distilled water. Nifedipine was dissolved under 
Na^ illumination in the minimum amount of cremophor necessary 
and diluted in Krebs. Solutions containing nifedipine were 
protected from the light. Reserpine was dissolved in glacial 
acetic acid (0.3 ml, I7.5M) and diluted with distilled water. 
Solutions containing only glacial acetic acid and distilled 
water served as controls. Luciferase-luciferin, supplied as 
a solid in glycine buffer, was dissolved in distilled water 
and the resulting solution protected from the light and kept 
at 4°C. (-)-7>8- -noradrenaline, supplied in 0.02M
acetic acid:ethanol (9:1; v:v) was resuspended in distilled 
water, containing ascorbic acid (3*7 x 10 ^M) to prevent 
breakdown of the catecholamine. 2,3';8- [ h^ ] - adenosine,
supplied in an aqueous ethanol solution (30%), was resuspended 
in distilled water. 6-Hydroxydopamine was dissolved by 
sonication in 0.9% saline containing ascorbic acid (3*7 x 
10"^M), kept at 4°C on ice and bubbled with O^-free N^ for 
at least 30 min prior to use. Solutions containing only 
ascorbic acid served as controls.
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CHAPTER 3 ; RESULTS
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ACTIONS OF CHANNEL ANTAGONISTS ON THE GUINEA-PIG VAS
DEFERENS
(i) Nerve AP conduction in vitro
APs were recorded» routinely» from a small hypogastric 
nerve bundle» in response to stimulation (0.5 Hz» O.O5-O.3 ms). 
Supramaximal stimulation (0.5 Hz» 0.3 ms) produced a discharge 
of several APs (Fig. 12a). These had a mean amplitude of 
0.2 - 0.02 mV (n = 66) and a latency of 26.9 - 2.0 ms (n = 60). 
The amplitude and latency of each AP varied» presumably 
reflecting their different diameters and conduction velocities. 
The mean duration of the AP discharges» in response to a single 
pulse (0.3 ms » supramaximal voltage)» was 28.7 - 2.8 ms (n = 30). 
The APs were postganglionic; hexaméthonium (1 x 10 M) was 
ineffective.
The pattern of AP discharge was related to current strength; 
single biphasic APs were obtained by reducing the stimulation 
voltage and/or pulse width (Fig. 12b). These had a mean 
amplitude of O .3 - 0.02 mV (n = 30) and a duration of 
2.7 - 0.1 ms (n = 30).
Perfusion of the vas deferens with either verapamil 
(0.3 - 2 X  10”^M)» diltiazem (l - 8 x  10 ^M)» amlodipine (0.3 - 
2 X  1 0  ^M)» nicardipine (0.3 - 1 x  1 0  ^M) or cobalt {k - 
6 X  10“^M)» inhibited both the amplitude and number of APs 
in a dose—dependent manner (Figs. 13 to 13)* The order of 
potency of the organic Ca^* channel antagonists was amlodipine > 
verapamil > diltiazem > nicardipine.
a. 10ms b. 1ms
20>iv 20jjV
Fiff. 12; APs, recorded extracellulaxly vitro> from a 
small bundle of guinea-pig hypogastric nerve fibres running 
to the vas deferens, in response to a. supramaximal (0.5 Hz,
0.5 ms) and b. submaximal stimulation (0.5 Hz, 0.1 ms, lOV). 
Supramaximal stimulation produced an AP discharge (mean 
duration of 28.7 - 2.8 ms, n = 30). The APs had a mean
amplitude of 0.2 - 0.02 mV (n = 66) and latency of 26.9 -
2.0 ms (n = 60). Submaximal stimulation produced single 
biphasic APs. These had a mean amplitude of O .3 - 0.02 mV
(n = 30) and duration of 2.7 - 0.1 ms (n = 30).
10msControl
]40pV
r2 X ICr^ M Dit. r4 X 10 Dit. r 3 X DU.
Fig. 13 : The dose-dependent inliibitory effect of diltiazem
(Dit.9 5 X 10 ^ - 8 X 10 ^M) on AP conduction vitro, in 
a small bundle of guinea-pig hypogastric nerve fibres running 
to the vas deferens, evoked by stimulation (0.5 Hz, 0.2 ms, 
supramaximal voltage). The time between each panel was I5 min.
20ms
Control
10"^ M Amid. 2 X Icr^ M Amid.rlU 11 Mill iU . I—-T
I yi
Fig. l4: The dose-dependent inhibitory effect of amlodipine
(Amid. , 3 X 10 ^ - 2 X  10 ^M) on AP conduction iji vitro, in 
a small bundle of guinea-pig hypogastric nerve fibres running 
to the vas deferens, evoked by stimulation (0.3 Hz, 0.2 ms, 
supramaximal voltage). The time between each panel was 13 min,
Control
10ms
I--- 1
r 2 X 10 Cob. 40;jV
4 X 10 Cob. r 6 X lO'^M Cob.
Fig. 15; The inhibitory effect of cobalt (Cob., 2 - 6 x 10 ^m ) 
on AP conduction dni vitro> in a small bundle of guinea-pig 
hypogastric nerve fibres running to the vas deferens, evoked 
by stimulation (0.5 Hz, 0.5 ms, supramaximal voltage).
Higher concentrations of cobalt, compared to the organic agents 
diltiazem and amlodipine (previous 2 figures), were required 
to inhibit the APs. The time between each panel was I5 min.
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The immediate effects of these antagonists were seen 
more clearly following bolus injection, than after perfusion. 
Lower concentrations were effective when added by injection, 
presumably because APs were blocked prior to the equilibration 
of drugs with the Krebs bathing solution. The initial effect 
of each antagonist was to inhibit, progressively, the latency 
and then to reduce the amplitude of the AP in either a graded 
or an ’all—or—none' manner, depending upon concentration 
(Fig. 16).
In contrast to the other antagonists, nifedipine, even
at very high concentrations (up to 5 x 10~^M), had no
significant effect on AP conduction (Fig. 17).
The ionic basis of the APs was examined to determine the
2+mechanism underlying the inhibitory effects of the Ca channel
antagonists. Removal of Ca^^ from the perfusing Krebs solution,
without ionic compensation, reduced the amplitude of single
2+biphasic APs; an effect reversed by readmission of Ca 
(Fig. 18). TTX (l X 10 ^M) and the local anaesthetic, 
lignocaine (0.5 - 2 x IG^^M), which block Na^ channels, each 
abolished APs (as shown for lignocaine in Fig. 19)» suggesting 
that Na"*" rather than Ca^^ carried the inward current of the 
AP.
(ii ) Neirve AP conduction jui yij[_o
APs were recorded in the anaesthetised guinea-pig from 
a small postganglionic bundle of hypogastric nerve fibres, 
in response to preganglionic stimulation (0.2 Hz, 0.1 — 0*5 ms, 
supramaximal voltage). Systemic blood pressure and heart rate 
were recorded simultaneously.
a. b. c. d. 1ms
]20^V
Fig. 16; The effect of verapamil (2.5 x 10 (b),
3.75 X 10 (c) and 1.25 x 10 (d)), compared with a
saline control (a), on AP conduction vitro. APs were 
recorded from a small bundle of guinea-pig hypogastric 
nerve fibres running to the vas deferens, in response to 
submaximal stimulation (3 pulses at 0.5 Hz, 0.2 ms, lOV).
In each trace the numbers refer to responses to 3 consecutive 
stimuli ; 1 taken immediately prior to and 2 and 3» respectively, 
2 and ks after addition of verapamil (b-d) or saline (a).
AP latency was increased initially by verapamil (2.5 x 10 ^M) 
and the amplitude then reduced in a graded (at 3*75 x 10 ^M) 
or 'all-or-none' manner (at 1.25 x 10 ^M). Verapamil was 
added by bolus injection to the bath rather than by perfusion.
Control r lO’^ M Nif, r 5 X 10‘^ M Nif. 10ms ]iog/jv
Fig. 17 : The lack of effect of nifedipine (Nif., 1 and
-3 \3 X 10 M) on AP conduction iji vi tro, in a small bundle of 
guinea-pig hypogastric nerve fibres running to the vas 
deferens. APs were evoked by stimulation (0.3 Hz, 0.3 ms, 
supramaximal voltage) of the hypogastric nerve trunk. 
Nifedipine, in contrast to the other Ca^* channel antagonists, 
was ineffective. The time between each panel was I3 min.
Fig. 18; The effect of Ca^"^-withdrawal from the 
perfusing Krebs solution, on AP conduction vitro, 
in a small bundle of guinea-pig hypogastric nerve 
fibres running to the vas deferens. APs were evoked 
by submaximal stimulation (3 pulses at 0.3 Hz, 0.1 ms, 
3V) of the hypogastric nerve trunk. Compared to the 
control (2.7 X 10 CaCl^ (a)); Ca^ **’-withdrawal 
produced a small reduction in AP amplitude (b), which 
was reversed upon readmission of CaCl^ (2.7 x 10"^M) 
to the perfusing Krebs solution (c). The time between 
each panel was I3 min.
a. 0.5ms
j20jüV
b.
c.
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APs were discharged following stimulation; their mean 
latency (28*3 - 1.6 ms, n = 60) and the duration of each 
discharge (35»1 - 2.3 ms, n = 20), evoked by single pulses 
(0.3 ms, supramaximal voltage), was similar to that found 
in vitro, although the amplitude (O.l - 0.01 mV, n = 60) was 
significantly smaller. Connective tissue and fascia surrounding 
the hypogastric nerves djo. vivo may have reduced the current 
density of the stimulus and consequently AP amplitude. Ganglia 
were present in the nerve pathway; pentolinium (O.l - 0.6 mg 
kg ^ i.v.) inhibited the APs (Fig. 20).
The mean heart rate was 273 - 8 beats min ^ (n = 3^) and 
the diastolic and systolic blood pressures, ^9*3 - 2.3 and 
73*8 - 3-3 mm Hg (n = 3^), respectively.
/ -1 \I.v. administration of either verapamil (0.01 - 0.3 mg kg ),
diltiazem (O.Ol - 0 .3 mg kg ^ ) or amlodipine (o.l - 1.6 mg kg ^ ),
reduced both blood pressure and, except for amlodipine which
was ineffective, heart rate (Fig. 21). AP conduction was
unaffected by each agent at these doses; the latency, area
and duration of the discharge, as analysed by computer, were
not significantly different from controls (Fig. 22). In
larger doses, verapamil, diltiazem and amlodipine (l, 1 and
3.2 mg kg~^ i.v. respectively), each produced a complete
cardiovascular collapse.
Verapamil was then injected i.a. via the external iliac
artery. When added in this way, higher doses of verapamil
could be given than were possible i.v.; the compound was
tolerated better by the guinea-pig, presumably due to its
Control
r0.3mgkg"1 pent,
O.loigkg'' Pent.
20ms
llOpV
 ^ 0.6(ïi9k9  ^ Pent»
Fig. 20; The dose-dependent i n h i b i t o r y  effect of pentoXinimm 
(Pent, j 0.1 - 0.6 mgkg ^ i.v.) on AP condnctionL in vivo, 
in a shielLI bundle of guinea-pig hypogastric  nerve fibres 
running to the vas deferens. APs were evoked by stiranilaition 
(0.2 Hz, 0.5 ms, supramaximal voltage) of the hypogastric 
nerve trunk. The time between each panel was 13 min-
a. b.
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Fig. 21 ; The effect (i s.e. mean, n = 6-8) of verapamil 
(O.Ol - 0,3 mgkg ^ , #-# ), diltiazem (O.Ol - O .3 mgkg ^ , 0-0 ) 
and amlodipine (O.l - 1.6 mgkg ^ , A — A  ), administered i.v., 
on a. the blood pressure (mm Hg) and b. the heart rate 
(min ^ ) of the anaesthetised guinea-pig. Verapamil, diltiazem 
and amlodipine, in descending order of potency, each produced 
a dose-dependent fall in blood pressure. Heart rate was 
reduced to a similar extent by verapamil and diltiazem, while 
amlodipine was ineffective.
Pig. 22; The lack of effect of verapamil (Verap., 0.01 - 
0.3 mgkg~^, - s.e. mean, n = 3)> diltiazem (Dit., 0.01 - 
0.3 mgkg~^, - s.e. mean, n = 4), and amlodipine (Amid.,
0.1 - 1.6 mgkg ^ , - s.e. mean, n = 4), administered i.v., 
on AP conduction vivo, in a small bundle of guinea-pig 
hypogastric nerve fibres running to the vas deferens.
APs were evoked by stimulation (0.2 Hz, O .3 ms, supra­
maximal voltage) of the hypogastric nerve trunk. The 
results, determined by computer analysis, are expressed 
-as a percentage of the control AP discharge, with respect 
to the latency (#--•) , area ( • — • ) and duration (#-*-#) ,
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delayed passage to the heart. Verapamil (l - 3 mg kg”^ i.a.) 
inhibited the APs; the duration and the area of the discharge 
were reduced and the latency increased (Figs. 23 and 2k).
The blood pressure and heart rate were also reduced in a dose- 
dependent fashion (Fig. 23).
Verapamil may have inhibited the APs by ganglion blockade, 
as presumably occurred with pentolinium, or by interfering 
with either pre— or postganglionic AP conduction. To determine 
which was the case, acetylcholine (O.Ol mg) was added i.a., 
when evoked APs had been blocked with either verapamil 
(3 mg kg ^ i.a.) or pentolinium (0.6 mg kg ^ i.v.). Activation 
of ganglionic nicotinic receptors by acetylcholine would 
discharge APs, only if its receptors and the postganglionic 
fibres were unaffected by either compound. During blockade of 
evoked APs by verapamil, but not by pentolinium, acetylcholine 
produced a spontaneous discharge of APs (Fig. 26). Thus, the 
ganglionic nicotinic receptors, blocked by pentolinium, and 
the postganglionic nerve fibres, were unaffected by verapamil. 
As a consequence of its lack of effect on postganglionic AP 
conduction, it is likely that preganglionic conduction was 
similarly unaffected and probable that verapamil blocked the 
evoked APs by inhibiting preganglionic transmitter release.
(iii) Excitatory .junction potentials
The actions of Ca^* channel antagonists on postganglionic 
transmitter release were next examined. E.j.ps were used as 
one measure of release.
Control 0.01mgkg"' Verap. 0.03mgkg“ Verap.
0.1mgkg"' Verap. 0.3mgkg"' Verap. rImgkg""* Verap.
Fig. 23: The dose-dependent inhibitory effect of verapamil
(Verap., 0.01 - 1 mgkg ^ i.a.) on AP conduction vivo, 
in a small bundle of guinea-pig hypogastric nerve fibres 
running to the vas deferens. APs were evoked by stimulation 
(0.2 Hz, 0.5 ms, supramaximal voltage) of the hypogastric 
nerve trunk. The time between each panel was 15 min.
200
150 -
><o 100 -
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Fig. 2k ; The dose-dependent inhibitory effect (- s.e. mean, 
n = 3) of verapamil (O.Ol - 3 mgkg ^ i.a.) on AP conduction 
in vivo, in a small bundle of guinea-pig hypogastric nerve 
fibres running to the vas deferens. APs were evoked by 
stimulation (0.2 Hz, 0.5 ms, supramaximal voltage) of the 
hypogastric nerve trunk. The results, determined by computer 
analysis, are expressed as a percentage of the control AP 
discharge, with respect to the latency (#--•), area (# — #) 
and duration (#-*-#).
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Fig. 25; The effect (- s.e. mean, n = 3,4) of verapamil 
(O.Ol - 1 mgkg i.a.) on a. the blood pressure (mm Hg) 
and b. the heart rate (min ^ ) of the anaesthetised guinea- 
pig. Verapamil produced a dose-dependent fall in both 
parameters.
Fig. 26; The effect of acetylcholine (ACh, 0.01 mg i.a.), 
compared to its vehicle, saline (Sal., 0.9% NaCl in distilled 
water, i.a.), on the resting electrical activity dm vivo, 
in a small bundle of guinea-pig hypogastric nerve fibres 
running to the vas deferens. Stimulation (0.2 Hz, 0.5 ms, 
supramaximal voltage)-evoked APs were blocked with either 
(a) verapamil (3 mgkg ^ i.a.) or (b) pentolinium (0.6 mgkg"^
i.v.). Acetylcholine produced a spontaneous discharge 
following blockade of stimulation-evoked APs by verapamil, 
but not by pentolinium. Saline was ineffective.
(a)
Control Sal. (0.9%) 0.2s
j20pV
Control ACh (O.Olmg)
(b)
Control Sal. (0.9%)
0.2s
Control ACh (O.Olmg)
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When first set up, the vas deferens had no tone. Each
preparation was then gently stretched to a tension of Ig,
which was well maintained throughout experiments. The smooth 
muscle of the vas deferens had a mean resting membrane potential 
of —55»5 — 0.4 mV (n = 113 cells) and frequently showed 
spontaneous e.j.ps with a mean amplitude of 5.0 - 0.4 mV
(n = 30), a duration of 85.9 - 4.3 ms (n = 50) and time to
peak of 20.0 - 1.3 ms (n = 50). These were unaccompanied by 
any increase in tone.
Field stimulation (5-20 pulses at 1 and 2 Hz, 0.1 - O .5 ms, 
supramaximal voltage) evoked e.j.ps, which at 1 Hz had a mean 
amplitude of 6.8 - 0.4 mV (n = 50), a latency of I3 .I - 1.0 ms 
(n = 50)> a duration of 724.7 - 22.8 ms (n = 50) and a time 
to peak of 56.8 - 3*4 ms (n = 50)' These values were comparable 
to those found in other investigations (Burnstock & Holman,
1961; Cunnane, 1979)* The e.j.ps facilitated in amplitude at 
1 Hz and summated at 2 Hz, successive e.j.ps arising during 
the falling phase of the preceding depolarization. They 
were inhibited by TTX (l x 10"^M), indicating their neural 
origin (Fig. 27)» E.j.ps summated to produce APs and a 
contraction. However, contractions were also recorded in 
the absence of APs in an impaled cell, presumably as a result 
of electrical activity (APs) in other cells.
Perfusion of the vas deferens with either verapamil 
(1 - 2 X  10”^M), diltiazem (l - 5 % lO'^M), amlodipine 
(0.5 - 1 X  10”^M) or cobalt (l x 10~^M), inhibited e.j.ps 
and muscle contractions in a dose-dependent manner (Figs. 28
Control
2 2
IO'®M TTX
i;-45mV65mV
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-60mV
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Fig. 27 : Intracellularly-recorded e.j.ps in response to 
field stimulation of the guinea-pig vas deferens (lO pulses 
at 1 Hz and 5> 10 and 20 pulses at 2 Hz> 0.1 ms> supramaximal 
voltage) in the absence (upper trace) and presence of TTX 
(l X  10 ^M). E.j.ps, which facilitated at 1 Hz and summated 
at 2 Hz, were abolished by TTX, indicating their mediation 
by nerves. The duration of stimulation is indicated by the 
horizontal bars and the frequency by the numbers underneath. 
The time between each trace was 15 min.
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to 30). The organic agents were each more potent in blocking 
muscle contractions than e.j.ps, while cobalt was equally 
effective. Nifedipine (5 x 10 ^M), unlike the other antagonists, 
had no effect on the e.j.ps, but inhibited both muscle APs 
and contractions (Fig. 31)•
(iv) Radiolabelled transmitter release
The effects of Ca^ "*" channel antagonists on transmitter 
release were measured directly. To do this, the sympathetic 
nerves were treated with radiolabelled transmitter material 
and the effect of the antagonists on the overflow measured.
(a) [^h ] -noradrenaline incubation
3
After commencing superfusion, the overflow of H from
the vas deferens declined exponentially, in the absence of
nerve stimulation (Fig. 32), reaching a steady value by 3 h,
at which time stimulation was carried out. Field stimulation
(60 pulses at 1-20 Hz, O.3 ms, supramaximal voltage) in the
presence of ascorbic acid (1.1 x 10 M) to prevent oxidation
of catecholamines, desipramine (6 x 10 M) and normetanephrine
(1 X  10 ^M) to inhibit uptake-1 and uptake-2 processes
respectively and atropine (2.6 x 10 ^M) to block any cholinergic
influence on release, increased H overflow (Fig. 33)» The
3
amount of evoked H overflow increased with increasing frequency 
of stimulation (maximum at 10-20 Hz, Fig. 34-) and was abolished 
by TTX (1 X  10”^M), indicating its mediation by nerves.
Fig. 28; The effect of diltiazem (Dit., 1 and 5 x 10~^M) 
on intracellularly-recorded e.j.ps (upper trace of each 
set) and accompanying mechanical activity in the guinea- 
pig vas deferens, in response to field stimulation (lO 
pulses at 1 Hz and 5 pulses at 2 Hz, 0.2 ms, supramaximal 
voltage). Diltiazem inhibited e.j.ps and contractions 
in a dose-dependent manner. Contractions were blocked by 
diltiazem at a time when e.j.ps were present. The 
duration of stimulation is indicated by the horizontal 
bars and the frequency by the numbers underneath. The 
time between each set was approximately 15 min.
oo3
o IXT
IVJ j
to\
vn
X
o IXT
[
vn«£>
L.
CT»
5
Control
1
5 X 10"^M Amid.
lO'^ M Amid.
Icr^M Amid.
-35mV
”55mV 
]o.5g
^s
n-35mV 
-65mV 
]o.5g
4S
Fig. 29 : The effect of amlodipine (Amid.> 1 x 10 ^ -
1 X 10 ^M) on intracellularly-recorded e.j.ps (upper trace 
of each set) and accompanying mechanical activity in the 
guinea-pig vas deferens, in response to field stimulation 
(10 pulses at 1 and 2 Hz, O .5 ms, supramaximal voltage). 
Amlodipine inhibited e.j.ps and contractions in a dose- 
dependent manner. The contractions were blocked at a lower 
concentration than the e.j.ps. The duration of stimulation 
is indicated by the horizontal bars and the frequency by 
the numbers underneath. The time between each set was 
approximately 15 min.
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Fig. 30; The effect of cobalt (Cob., 1 x 10 ^M) on 
intracellularly-recorded e.j.ps (upper trace of each 
set) and accompanying mechanical activity in the guinea- 
pig vas deferens, in response to field stimulation (lO pulses 
at 1 Hz and 5 and 10 pulses at 2 Hz, 0.5 ms, supramaximal 
voltage). Cobalt abolished contractions and produced an 
almost complete blockade of e.j.ps. The duration of 
stimulation is indicated by the horizontal bars and the 
frequency by the numbers underneath. The time between the 
two sets was 25 min.
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Fig. 31: The effect of nifedipine (Nif., 5 x IO^^M)
on intracellularly-recorded e.j.ps (upper trace of
each set) and accompanying mechanical activity in the
guinea-pig vas deferens, in response to field stimulation
(lO pulses at 1 Hz and 5 and 10 pulses at 2 Hz, O .3 ms,
supramaximal voltage). Nifedipine, in contrast to the 
2+other Ca channel antagonists examined, had no effect 
on the e.j.ps but inhibited both muscle APs and mechanical 
contractions. The duration of stimulation is indicated 
by the horizontal bars and the frequency by the numbers 
underneath. The time between the two sets was 20 min.
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Fig. 32: The exponential decline with time in the resting
overflow, expressed as DPM/sample (x 10^), from the 
guinea-pig vas deferens incubated with [^h ] -noradrenaline. 
By 3 h, approximately, H overflow had reached a relatively 
steady value, enabling an accurate assessment to be made of 
the effects of field stimulation and of drugs.
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Fig. 33î The effect of field stimulation (60 puises at 
If 5> 10 and 20 Hz, 0.5 ms, supramaximal voltage) on the 
resting overflow, expressed as DPM/sample (x 10^), from
the guinea-pig vas deferens incubated with -noradrenaline.
3,Stimulation produced a frequency-dependent increase in H 
overflow. The following drugs were present throughout: 
ascorbic acid (l.l x 10”^M) to prevent oxidation of 
catecholamines, desipramine (6 x 10 M) and normetanephrine 
(l X  10"”-^ M) to inhibit, respectively, uptake-l and uptake-2 
processes and atropine to block any cholinergic influence on 
release.
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Fig. 34 : H overflow» expressed as the fractional release
per pulse of stimulation (- s.e. mean, n = 12)» evoked by- 
field stimulation (6o pulses at 1» 5» 10 and 20 Hz, 0.5 ms, 
supramaximal voltage) of the guinea-pig vas deferens incubated
with [^h ] -noradrenaline. "^ H overflow increased with the 
frequency of stimulation, reaching a maximum between 10 and 
20 Hz.
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The major constituents in the resting overflow, as 
revealed by chromatography, were 4-hydroxy 3-methoxymandelic 
acid (VMA) and 4-hydroxy 3-methoxyphenylglycol (MOPEG), 3,4- 
dihydroxyphenylglycol (DOPEG) and noradrenaline (Fig. 33a).
Field stimulation (300 pulses at 20 Hz, 0.5 ms, supramaximal 
voltage) released mainly noradrenaline (Fig. 35b).
Cobalt (2 X  10 ^M), while having little effect on the
Q
resting H level, significantly inhibited stimulation (6o 
pulses at 1-20 Hz, 0.5 ms, supramaximal voltage)-evoked
O
overflow of H at each frequency (Fig. 3^).
Verapamil (O.l - 1 x 10 ^M), diltiazem (0.5 - 1 x 10 ^M),
amlodipine (O.O5 - 1 x 10 ^M) and nifedipine (l - 5 x 10 ^M),
3
each markedly increased the resting H overflow in a dose-
dependent manner (Figs. 37 to 39)* This effect obscured any 
3
increase in H overflow which may have been produced by nerve
stimulation. In contrast to that produced by field stimulation,
the principal constituent released by either amlodipine
(5 X 10 ^M, Fig. 4 o )  or verapamil (l x 10 Fig. 4 l ) was
DOPEG. The amounts of VMA and MOPEG, DOHA, NMN or noradrenaline
itself, were not affected significantly by either compound.
3
The source of the increased resting H overflow was 
examined in vasa of guinea-pigs pretreated with 6-hydroxydopamine 
(150 mgkg“^ on day 1 and 250 mgkg"^ on day 2; experiments on 
day 3 ) to destroy the sympathetic innervation. Destruction 
was confirmed by the absence of fluorescence (Fig. 42), using 
a modification of the Falck histofluorescence technique 
(Gillespie & Kirpekar, I966). Following 6-hydroxydopamine
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Fig. 35? The relative amounts (- s.e. mean, n = 12) of 
-noradrenaline and its metabolites, expressed as a 
percentage of the total disintegrations per minute (DPM),
3
in a sample of the H overflow, a. at rest and b. following 
field stimulation (300 pulses at 20 Hz, 0.5 nis, supramaximal 
voltage) of the guinea-pig vas deferens. At rest, -
labelled 4-hydroxy 3-methoxymandelic acid (VMA) and 4- 
hydroxy 3-methoxyphenylglycol (MOPEG), 3>4-dihydroxyphenylglycol 
(DOPEG) and noradrenaline (NA) were the major constituents.
Only small amounts of [^h ] -normetanephrine (NMN) and 3>4- 
dihydroxymandelic acid (DOMA) were found. Following field 
stimulation [ h^ ] -noradrenaline was the principal product.
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Fig. 36: H overflow, expressed as the fractional release
per pulse of stimulation (- s.e. mean, n = 3) , evoked by- 
field stimulation (60 pulses at 1, 5> 10 and 20 Hz, 0.3 ms, 
supramaximal voltage) of the guinea-pig vas deferens 
incubated with [^ hJ -noradrenaline, in the absence (O-O) and 
presence (#-#) of cobalt (2 x IO^^M). overflow was
significantly (*, p < O.O3) inhibited by cobalt at each
—4 —7frequency. Ascorbic acid (l.l x lO” M), desipramine (6 x 10 M),
normetanephrine (l x 10 ^M) and atropine (2.6 x 10 M) were 
present throughout (see legend for Fig. 33)•
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Fig« 37 : The effect of verapamil (l x 10 M for the period
r>
indicated by the horizontal bar) on the resting H overflow, 
expressed as DPM/sample (x 10^), from the guinea-pig vas 
deferens incubated with | HI -noradrenaline. Verapamil markedly
3 —4increased the resting H overflow. Ascorbic acid (l.l x 10 M), 
desipramine (6 x 10 ^M), normetanephrine (l x 10 ^M) and 
atropine (2.6 x 10 ^M) were present throughout (see legend 
for Fig. 33).
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Fig. 38: The effect (- s.e. mean, n = 3) of verapamil
(l X  l o ” ^ - 1 X  10 ^M), expressed as a percentage of the
control (lOO%), on the resting H overflow from the guinea-pig
vas deferens incubated with [^h ] -noradrenaline. Verapamil
3
produced a dose-dependent increase in the resting H overflow.
OCD
Q.
E
CD
CO
Q_Q
1 2 0 - ,
1 0 H z
1 0 0 -
; 5 H z
80 _ 1 H z
2 0 H z60 -
40 -
1 0 H z20 -
“ I 1- - - - - 1- - - - - 1- - - - - r
22 0  2 4 0  2 6 0  2 8 0  300
Time (min)
Fig. 39? The effect of amlodipine (5 x 10 for the period
O
indicated by the horizontal bar) on H overflow, expressed 
as DPM/sample (x 10^), evoked by field stimulation (60 pulses 
at 1, 10 and 20 Hz, 0.5 ms supramaximal voltage) of the
guinea-pig vas deferens incubated with [^h ] -noradrenaline.
3
Amlodipine increased the resting H overflow sufficiently to 
mask the effect of field stimulation at each frequency.
—4 —yAscorbic acid (l.l x 10 M), desipramine (6 x 10 M),
normetanephrine (l x 10 ^M) and atropine (2.6 x 10 ^M) were 
present throughout (see legend for Fig. 33)»
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Fig. k O : The effect (- s.e. mean, n = 3) of amlodipine
(5 X 10 ^M), expressed as a percentage change from the 
resting, control, overflow levels of [^h] -noradrenaline 
and its metabolites in the guinea-pig vas deferens.
Amlodipine significantly (*, p < O.O5) increased the level 
of [^hJ -3>^“dihydroxyphenylglycol (DOPEG), but had no 
significant effect on the levels of [^h] -4-hydroxy 3- 
methoxymandelic acid (VMA) and 4-hydroxy 3-methoxyphenylgTycol 
(MOPEG), normetanephrine (NMN), 3>4-dihydroxymandelic acid 
(DOMA) or noradrenaline (NA).
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Fig. 4l : The effect (- s.e. mean, xi = k) of verapamil (l x
10 ^M), expressed as a percentage change from the resting, 
control, overflow levels of [^HJ -noradrenaline and its 
metabolites in the guinea-pig vas deferens. Verapamil 
significantly (*, p < O.O5) increased the level of [^h] - 
3>4-dihydroxyphenylglycol (DOPEG), but had no significant 
effect on the levels of [^h] -4-hydroxy 3-methoxymandelic 
acid (VMA) and 4-hydroxy 3-methoxyphenylglycol (MOPEG), 
normetanephrine (NMN), 3>4-dihydroxymandelic acid (DOMA) 
or noradrenaline (NA).
Fig. 4-2; The effect of 6-hydroxydopamine pretreatment 
(150 mgkg~^ i.p. on day 1 and 250 mgkg ^ on day 2; 
experiments on day 3) on the catecholamine content of 
the guinea-pig vas deferens, determined by histo­
fluorescence (Gillespie & Kirpekar, I966).
a) Fluorescence (magnification x 25) of catecholamine- 
containing neurones in the vas deferens from control 
guinea-pigs (pretreated with the drug vehicle, ascorbic acid),
b) The absence of fluorescence (magnification x 25); 
indicating destruction of catecholamine-containing neurones 
by 6-hydroxydopamine pretreatment.
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pretreatment, the effect of verapamil (l x 10”^M) on the
3
resting overflow of H, compared to that in untreated vasa, 
was greatly reduced (Fig. 43). Thus, the origin of the
3
increased H overflow appeared to be the sympathetic nerves.
— 4 3The effect of verapamil (l x 10 M) on the resting H overfl
was unaffected by removal of Ca^^ from the superfusing Krebs
solution. This suggested that inhibition of Ca^^ influx was
not involved in the action of verapamil.
ow
(b )  jZ a -adenosine incubation
3
The resting overflow of H from the vas deferens declined
3
exponentially. The amount of H released by field stimulation,
3
measured 128 min after commencing superfusion, when H overflow 
had reached a steady value, was poor compared to that following 
incubation with [^h] -noradrenaline. Accordingly, the 
conditions of field stimulation adopted (400-2000 pulses at 
20 Hz, 0.5 ms, supramaximal voltage) were more severe. Moreover, 
to inhibit the muscle contractions, which contribute to the 
overflow of (Fredholm aT. , 1982; Westfall et al. , 1978), 
a hypertonic Krebs solution containing sucrose (0.37M) was 
superfused. a, P meATP and prazosin (both 5 x 10 ^M) were 
also added to prevent the postjunctional effects of ATP and 
noradrenaline respectively (Sneddon & Westfall, 1984). Under
3
these conditions, field stimulation produced an increase in H 
overflow, which declined in magnitude after 3 stimulation 
periods. The same tissue could not be used to measure the 
evoked overflow in both the absence and presence of drugs.
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Fig. 43: The effect of verapamil (l x 10~ M for the period
indicated by the horizontal bar) on the resting overflow,
expressed as DPM/sample (x 10^), in the guinea-pig vas deferens
incubated with [ ^ h ]  - noradrenaline. The animal was pretreated
with 6-hydroxydopamine (l^O mgkg”^ i.p. on day 1 and 250 mgkg 
on day 2; experiments on day 3) to destroy the sympathetic
r>
innervation. Verapamil increased the resting overflow of H, 
but to a lesser extent than in tissues from untreated animals 
(Fig. 37)' Ascorbic acid (l.l x 10”^m ), desipramine (6 x 
10 ^M), normetanephrine (l x 10 ^M) and atropine (2.6 x 10”^M) 
were present throughout (see legend for Fig. 33)*
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Accordingly, one vas from each guinea-pig was used for drug 
treatment and the contralateral tissue for the control.
3
The amount of H in the resting overflow from each tissue 
varied greatly (e.g. Fig. 46), even between control preparations. 
The cause of this variation is unknown.
3
The stimulation—evoked increase in H overflow originated 
from nerves; it was prevented by TTX (2 x 10~^M, Fig. 44). 
Verapamil (l x 10 ^M, Fig. 45) had little effect on the resting
overflow of when —adenosine was used. Stimulation-
evoked overflow was inhibited by diltiazem (5 x 10”^M) and 
cobalt (2 X  10 ^M, Fig. 46), but was unaffected by nifedipine
(5 X ICT^M, Fig. 47).
ACTIONS OF Ca^+ CHANNEL ANTAGONISTS ON THE RAT ANOCOCCYGEUS
(i) Nerve AP conduction iji vitro
A discharge of APs was recorded from a small genito­
femoral nerve bundle in response to stimulation (single pulses, 
0.1 - 0.5 ms, supramaximal voltage). The APs had a mean 
amplitude of 0.1 - 0.1 mV (n = 74) and a latency of 10.5 - 0.8 
(n = 77). The AP discharges in response to a single pulse
lasted 18.8 - 1.0 ms (n = 20). There were no ganglia in the
—4nerve pathway; hexaméthonium (l x  10 M) was ineffective.
Na"*" involvement in the APs was indicated by the inhibitory 
action of TTX (2 x 10 ^M) .
Perfusion with either verapamil (O.l - 5 x 10 ^M) ,
—4  o
nifedipine (O.Ol - 1 x 10“ M) or cobalt (0.05 - 1 x 10“ M), 
inhibited the APs in a dose-dependent manner (Figs. 48 to 50).
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Fig. 44: H overflow, expressed as DPM/sample (x 10 ), from
guinea-pig vasa incubated with [^h ] -adenosine, in the 
absence (O-O) and presence (•-•) of TTX (2 x 10”^M). TTX
3
prevented H overflow in response to field stimulation 
(2000 pulses at 20 Hz, 0.3 ms, supramaximal voltage),
3
indicating that the H originated from nerves. Sucrose 
(0.37M), a, 1^ me ATP and prazosin (both 3 x 10 ^M) were present 
throughout, to inhibit contractions which contribute to the 
release of ATP (Westfall et al., 1978). Vasa from the same 
animal were superfused separately, but stimulated simultaneously.
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Fig. 45; The effect of verapamil (l x lO^^M for the period 
indicated by the horizontal bar) on the resting overflow, 
expressed as DPM/sample (x 10^), from the guinea-pig vas 
deferens incubated with [^h ] -adenosine. Verapamil had little
3
effect on the resting H overflow compared with its effect 
on vasa incubated with [^h ] -noradrenaline (Fig. 37)*
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Fiff» 46; overflow, expressed as DPM/sample (x 10^), from
guinea-pig vasa incubated with [ h^ ] -adenosine, in the absence 
(O-O) and presence (#-#) of cobalt (2 x 10 ^m ). Cobalt 
prevented overflow in response to field stimulation (2000 
pulses at 20 Hz, 0.3 ms, supramaximal voltage). Sucrose 
(0.37M), a, 1^ me ATP and prazosin (both 3 x 10 ^M) were present 
throughout, to inhibit contractions. Vasa from the same 
animal were superfused separately, but stimulated simultaneously.
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Fig» 47 : H overflow, expressed as DPM/sample (x 10 ), from
guinea-pig vasa incubated with [^h ] -adenosine, in the
absence (O-O) and presence (•-•) of nifedipine (5 x 10 ^M).Nifedip'
ine had no effect on overflow in response to field
stimulation (2000 pulses at 20 Hz, 0»5 ms, supramaximal 
voltage). Sucrose (0»37M), a, # meATP and prazosin (both 
3 X 10 ^M) were present throughout, to inhibit contractions.
Vasa from the same animal were superfused separately, but 
stimulated simultaneously.
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Fig. 4-8; The effect of verapamil (Verap. , 1 x lO”^ - 
5 X 10 ^M) on AP conduction vitro> in a small bundle 
of genito-femoral nerve fibres running to the rat 
anococcygeus. Verapamil inhibited the APs evoked by 
stimulation (single pulses, 0.5 ms, supramaximal 
voltage) of the genito-femoral nerve trunk, in a dose- 
dependent manner. Both the number and amplitude of APs 
were reduced. The time between each panel was 15 min.
Control
10ms
l20^V
r1 X ICr^ M Nlf. r5 X ICr^ M Nlf. r1 X Icr^ M Nlf.
The effect of nifedipine (Nif., 1 x 10 ^ -
—4 \1 X 10 M) on AP conduction vitro » in a small bundle 
of genito-femoral nerve fibres running to the rat 
anococcygeus. Nifedipine inhibited the APs evoked by- 
stimulation (single pulses, 0.3 ms, supramsLximal voltage) 
of the geni to-f emoral nerve trunk, in a dose-dependent 
manner. The time between each panel was I3 min.
Control
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Fig. 30: The effect of cobalt (Cob., 3 x 10 - 1 x lO” M)
on AP conduction vitro, in a small bundle of genito-femoral 
nerve fibres running to the rat anococcygeus. Cobalt 
inhibited, dose-dependently, the APs evoked by stimulation 
(single pulses, 0.3 ms, supramaximal voltage) of the 
genito-femoral nerve trunk. The time between each panel 
was 13 min.
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It was intended to study the effects of these agents 
on AP conduction in the NANC nerve fibres running to the 
rat anococcygeus. This appeared feasible since NANC and 
sympathetic nerve fibres are separate in this tissue and 
inhibitory responses present in 6-hydroxydopamine-treated 
animals (Gibson & Gillespie, 1973)* To destroy selectively 
the sympathetic innervation, rats were pretreated with 
reserpine (1 mgkg i.p. daily for the first 3 days) and 
6-hydroxydopamine (13O mgkg ^ i.p. on day 4 and 25O mgkg ^ 
on day 3; experiments on day 6). Destruction was achieved; 
there were no catecholamine-containing nerve fibres, as 
indicated by the absence of fluorescence (Gillespie & Kirpekar, 
1966; Fig. 31)> nor were contractions observed in pretreated 
tissues following extrinsic nerve stimulation. APs and NANC- 
mediated relaxations, recorded in separate experiments, were, 
however, evident following pretreatment. The APs were similar 
to those recorded from untreated tissues, with respect to 
their amplitude and latency. Perfusion with either verapamil 
(0.03 - 2 X 10”^M) or cobalt (o.l - I .3 x 10 ^M), at similar 
concentrations to those effective in untreated nerves, inhibited 
the APs (Figs. 32 and 33)*
Together, the results of these observations are at best 
equivocal. It is likely that pretreatment with reserpine and 
6-hydroxydopamine destroyed some sympathetic nerve fibres.
There is, however, no evidence that the fibres from which APs 
were subsequently recorded, were exclusively NANC, although 
it was clear that mechanical responses to NANC (but not 
sympathetic) nerve stimulation persisted following pretreatment.
Fig. 5 1 : The effect of reserpine (l mgkg ^ i.p.
daily for the first 3 days) and 6-hydroxydopamine 
(150 mgkg~^ i.p. on day 4 and 250 mgkg ^ on day 5; 
experiments on day 6) on the catecholamine content 
of the rat vas deferens, determined by histofluorescence 
(Gillespie & Kirpekar, I966).
a) Fluorescence (magnification x 25) of catecholamine- 
containing neurones in the vas deferens from control 
rats (pretreated with the drug vehicles, glacial 
acetic acid and ascorbic acid).
b) The absence of fluorescence (magnification x 25), 
indicating destruction of catecholamine-containing 
neurones by reserpine and 6-hydroxydopamine pretreat­
ment .
a.
/
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-k X2 X 10 M) on AP conduction dm vitro » in a small bundle
of genito-femoral nerve fibres running to the rat anococcygeus
/ -1The animal was pretreated with reserpine (1 mgkg i.p. 
daily for the first 3 days) and 6-hydroxydopamine (I50 mgkg ^ 
i.p. on day k and 250 mgkg  ^ on day 5j experiments on day 6) 
to destroy the sympathetic innervation. Verapamil inhibited 
the APs in response to stimulation (single pulses, 0.5 ms, 
supramaximal voltage) of the genito-femoral nerve trunk, in 
a dose-dependent manner. These APs may have originated from 
NANC nerve fibres (see text). The time between each panel was 
15 min.
C o n t r o l
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Fiæ* 53 : The effect of cobalt (Cob., 1 x 10 ^ - I .5 x 10 ^M)
on AP conduction vitro » in a small bundle of genito-femoral 
nerve fibres running to the rat anococcygeus. The animal 
was pretreated with reserpine (1 mgkg ^ i.p. daily for the 
first 3 days) and 6-hydroxydopamine (I30 mgkg  ^ i.p. on day 
4 and 250 mgkg ^ on day 3; experiments on day 6) to destroy 
the sympathetic innervation. Cobalt inhibited, dose-dependently, 
the APs in response to stimulation (single pulses, 0.3 ms, 
supramaximal voltage) of the geni to-f emoral nerve tmnk. These 
APs may have originated from NANC nerve fibres (see text).
The time between each panel was I3 min.
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(ii ) Excitatory .junction potentials
To assess the effects of the antagonists on transmitter 
release in the anococcygeus, e.j.ps, in response to extrinsic 
nerve stimulation, were measured intracellularly using glass 
microelectrodes.
When first set up, the anococcygeus had no tone. Each
preparation was then gently stretched to a tension of
approximately Ig, which was maintained throughout each experiment.
The smooth muscle of the anococcygeus had a mean resting 
membrane potential of -70.1 - O.3 mV (n = l40 cells). No
spontaneous electrical activity was present.
Stimulation (5 pulses at 5-20 Hz, 0.1 - 0.5 ms, supra­
maximal voltage) of the genito-femoral, together with the 
perineal branches of the pudendal nerve running to the ano­
coccygeus, evoked an e.j.p. and contraction. Two types of 
e.j.ps, possessing different rates of rise, were evident. In 
80% of cells (Fig. 54a), stimulation with 5 pulses at 10 and 
20 Hz evoked e.j.ps with a short time to peak. These 'fast' 
e.j.ps, up to 40 mV in amplitude with a mean duration of
1.0 - 0.03 3 (n = 35); were followed by a 'slow' e.j.p. which 
lasted several seconds (4.7 - 0.3s, n = 3I ) and had a mean 
amplitude of 4.8 - 0.4 mV (n = 36). In these cells, stimulation 
with 5 pulses at 5 Hz generally produced only a 'slow' e.j.p.
In the remainder of cells, only 'fast' e.j.ps were observed 
(Fig. 54b). TTX (1 X 10"^M) inhibited both e.j.ps and 
contractions, indicating their mediation by nerves.
1 -ôOfnV
- “80mV
] 0.5g
2s
b. 1 -60mV
5/5 5/10 5/20
-SOrnV
]o. 5 g
2s
Fig. 3^î Intracellular electrical (upper trace) and 
accompanying contractile activity in the rat anococcygeus, 
evoked by stimulation (5 pulses at 3, 10 and 20 Hz, 0.3 ms, 
supramaximal voltage) of both the genito-femoral and perineal 
branches of the pudendal nerve. a. E.j.ps evoked by stimulation 
(3 pulses) at 10 and 20 Hz, in some 80fo of cells, consisted of 
a 'fast' and 'slow' component and were accompanied by mechanical 
contractions. Stimulation (3 pulses) at 3 Hz normally produced 
only a 'slow' e.j.p. b. 'Fast' e.j.ps only, again accompanied 
by a contraction, were observed in approximately 20% of cells.
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Verapamil (o.l - 5 x 10“^m), nifedipine (O.Ol - 1 x 10~^M) 
and cobalt (0.5 - 2 x 10 ^M), each inhibited, in a dose-dependent 
manner, both evoked (5 pulses at 5-20 Hz, 0.5 ms, supramaximal 
voltage) 'fast' and 'slow' e.j.ps and contractions (Figs. 55 to 
57)' The organic agents were each more potent in blocking 
muscle contractions than in reducing the e.j.ps, while cobalt 
was equally effective against both parameters.
ACTIONS OF Ca^+ CHANNEL ANTAGONISTS ON THE GUINEA-PIG INTERNAL 
ANAL SPHINCTER
(i) Inhibitory junction potentials
I.j.ps were used as a measure of NANC transmitter release. 
The i.a.s., when first set up, had no tone. Following 
gentle stretch (ig), however, some 2-3g developed spontaneously 
and persisted for several hours, accompanied frequently by 
oscillations in tone. Tone was myogenic; it was unaffected by 
either cholinoceptor (e.g. atropine, 1 x 10 ^M) or adrenoceptor 
(e.g. phentolamine, 1 x 10 ^M) antagonists, or by TTX (l x 10 ^M) 
There was a spontaneous spike discharge in the i.a.s., 
two different patterns of which were evident (Fig. 58). The 
first, observed in 40% of cells, consisted of large (up to 
60 mV) spikes, discharging at 1-2 Hz. Each spike was preceded 
by a slow membrane depolarization, characteristic of pacemaker 
activity (Bennett, 1972) and followed by a hyperpolarization 
of some 5-7 mV. The second type consisted of smaller spikes 
(2-3 Hz, 30-40 mV in amplitude), which could be either 
continuous or intermittent, often superimposed on a membrane 
depolarization. The mean resting membrane potential, measured
Fig. 55; The dose-dependent inhibitory effect of 
verapamil (Verap., 1 x 10 ^ - 5 x 10 ^M) on 
intracellularly-recorded e.j.ps (upper trace of each 
set) and accompanying contractions in the rat 
anococcygeus, in response to extrinsic nerve stimulation 
(5 pulses at 5> 10 and 20 Hz, 0.5 ms, supramaximal 
voltage). The contractions were inhibited before the 
e.j.ps. The time between each set was approximately 
15 min.
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Fig» 56 : The dose-dependent inhibitory effect of
nifedipine (Nif.» 1 x 10 — 1 x 10 M) on
intracellularly-recorded e.j.ps (upper trace of 
each set) and accompanying contractions, evoked by 
extrinsic nerve stimulation (5 pulses at 3» 10 and 
20 Hz, 0.3 ms, supramaximal voltage), in the rat 
anococcygeus. As with verapamil (Fig. 35)» 
nifedipine inhibited the contractions before the 
e.j.ps. In this experiment^ the effects of 
nifedipine on nerve AP conduction (Fig. 4^) were 
studied simultaneously with its actions on release. 
The time between each set was approximately I3 min.
Control
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1 -55mV
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]0.5g
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-* -80mV 
]0.5g
-55mV
-80mV
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/ - kFig. 57 : The effect of cobalt (Cob., 5 x 10 -
2 X 10 ^M) on intracellularly-recorded e.j.ps
(upper trace of each set) and accompanying
contractions in the rat anococcygeus, in response
to extrinsic nerve stimulation (5 pulses at 10
and 20 Hz, O .5 ms, supramaximal voltage). Cobalt
was equally effective at inhibiting both e.j.ps
and contractions. The time between each set was
approximately I5 min.
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Fig. 38? Spontaneous electrical (upper trace of each set) 
and accompanying mechanical activity in the guinea-pig i.a.s
a. Large spikes (seen in kO% of cells) of some 60 mV in 
amplitude preceded by a slow depolarization and accompanied 
by an after-hyperpolarization and oscillations in tone.
b. Smaller spikes (seen in 60% of cells), either continuous 
(left hand trace) or intermittent, of 30-40 mV in amplitude, 
often superimposed on a membrane depolarization.
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between spontaneous spikes, was -43*5 - 0.3 mV (n = 135 cells).
In the presence of tone, field stimulation (single pulses 
and trains of 5 pulses at 5 and 10 Hz, 0.5 ms, supramaximal 
voltage) inhibited spike discharge, hyperpolarized the membrane 
producing an inhibitory junction potential (i.j.p.) and relaxed 
tone (Fig. 59)» Single stimuli produced i.j.ps of up to 30 mV 
in amplitude (l6.4 - 0.8 mV, n = 30) with a mean latency of
112.0 - 5*1 ms (n = 20), a duration of 815*0 - 40.2 ms (n = 20) 
and a time to peak of 231*2 - 12.7 ms (n = 20). Upon stimulation 
with 5 pulses at 5 and 10 Hz (0.3 ms, supramaximal voltage), 
the i.j.ps summated. A post-stimulus increase in spike frequency 
and a rebound contraction, common characteristics of the 
responses to NANC nerve stimulation (Bennett e_t ad. , I966; 
Furness, I969)» were often observed. I.j.ps were not signifi­
cantly affected by hexaméthonium (1 x 10 ^M), but were abolished 
by TTX (1 X 10 ^M), confirming their postganglionic neural 
origin. The i.j.ps were mediated by NANC nerves; they were 
unaffected by atropine, phentolamine and guanethidine (each 
1 X 10”^M), perfused in the Krebs solution throughout each 
experiment.
Perfusion of the i.a.s. with either verapamil (O.Ol -
1 X 10”^M), diltiazem (0.03 - 5 x 10 ^M), nifedipine (O.Ol -
3 X 10”^M) or cobalt (l x 10 ^M), inhibited both spontaneous
and evoked electrical and mechanical responses. The organic
agents, in low doses (l - 3 x 10”"^M), each blocked both the
spontaneous spikes and tone, but had no inhibitory effect on
/ -4the i.j.ps, except at higher concentrations (1 - 3 x 10 M,
5 / 5SS 5 / 1 0
OmV
“* - 6 0 m V
] 2 . 5 g
2s
Pig. 5 9 : Intracellular electrical (upper trace) and
accompanying mechanical responses in the guinea-pig i.a.s., 
evoked by field stimulation (single pulse(ss) and 3 pulses 
at 5 and 10 Hz, 0.5 ms, supramaximal voltage) of NANC inhibitory 
nerves. Atropine, phentolamine and guanethidine (each 1 x 
10 ^M) were present throughout. Field stimulation inhibited 
the spontaneous spikes, hyperpolarized the membrane to give 
an i.j.p. and relaxed the tone.
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Figs. 60 and 61). Cobalt (l x 10 ^M) inhibited, with equal 
effectiveness, both electrical and mechanical responses in 
the i.a.s. (Fig. 62).
(ii) Radiolabelled transmitter release
The i.a.s. was incubated with -adenosine and the
effects of the drugs on the overflow determined. If, as has 
been suggested (Lim, I985; Lim & Muir, I986), ATP is the 
NANC transmitter in this tissue, the nerves should accumulate
and release this compound or its metabolites (Su et al., I971).
3
In the absence of stimulation, the overflow of H from
the i.a.s. declined exponentially. Field stimulation (200-900
pulses at 2-20 Hz, O .5 ms, supramaximal voltage) and drug
additions were carried out 86 min after commencing superfusion,
3
when H overflow had reached a steady level. Field stimulation,
in the presence of atropine,phentolamine and guanethidine
(each 1 X  10 ^M), increased ^H overflow from the i.a.s. and
produced a relaxation. TTX (l x 10 ^M) inhibited these
responses, indicating their mediation by nerves (Fig. 63).
Two additional experiments were carried out to confirm
3
that the stimulation-evoked overflow of H arose from the NANC 
nerves, rather than from the relaxation of the muscle per se. 
First, Ca^^, necessary for transmitter release (Katz & Miledi,
1965), was withdrawn from the superfusing Krebs solution,
3
without compensation. This increased the resting H overflow 
substantially and abolished tone (Fig. 64). Field stimulation 
(900 pulses at 2 and 5 Hz, O .5 ms, supramaximal voltage) now
Fig. 60 ; The effect of verapamil (l x 10 ^ and 
1 X  IO^^M) on the intracellular electrical (upper 
trace in each set) and accompanying mechanical 
responses in the guinea-pig i.a.s., evoked by field 
stimulation (single pulse (ss) and 3 pulses at 5 and 
10 Hz, 0.5 ms, supramaximal voltage) of NANC inhibitory 
nerves. Atropine, phentolamine and guanethidine (each 
1 X  10 ^M) were present throughout. Verapamil (l x 10 M^) 
inhibited the spontaneous spike discharge and reduced 
tone (as indicated by the arrow), but had no effect 
on the i.j.ps. When the concentration was increased
-4to 1 X 10 M, the i.j.ps were abolished. The time 
between each set was approximately 15 min.
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Fig» 6l; The effect of nifedipine (l x 10 ^ and 
5 X 10~^M) on the intracellular electrical (upper 
trace in each set) and accompanying mechanical 
responses in the guinea-pig i.a.s., evoked by field 
stimulation (single pulse (ss) and 5 pulses at 5 
and 10 Hz, O .5 ms, supramaximal voltage) of NANC 
inhibitory nerves. Atropine, phentolamine and 
guanethidine (each 1 x 10 ^M) were present throughout. 
Nifedipine (l x 10 ^M) inhibited the spontaneous 
spike discharge and reduced tone (as indicated by 
the arrow) but had no effect on the i.j.ps. When 
the concentration was increased to 5 x 10 ^M, the 
i.j.ps were abolished. The time between each set 
was approximately I5 min.
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Pig. 62; The effect of cobalt (1 x 10 ^m) on the intracellular 
electrical (upper trace of each set) and accompanying mechanical 
responses of the guinea-pig i.a.s., evoked by field stimulation 
(single pulse (ss) and 5 pulses at 3 and 10 Hz, 0.3 ms, 
supramaximal voltage) of NANC inhibitory nerves. Atropine, 
phentolamine and guanethidine (each 1 x 10 ^M) were present 
throughout. Cobalt inhibited the spontaneous spike discharge 
and abolished both the i.j.ps and tone. The time between the 
two sets was 13 min.
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Fig. 63 : overflow (upper graph) and simultaneously-
recorded mechanical relaxations (lower trace) of the 
guinea-pig i.a.s., evoked by field stimulation (900 pulses 
at 2, 5 and 20 Hz, 0.5 ms, supramaximal voltage), in the 
absence and presence of TTX (1 x 10 for the period 
indicated by the horizontal bar). The mechanical 
relaxations produced by field stimulation were accompanied
3
by an increase in H overflow. Both were inhibited by 
TTX indicating their mediation by nerves. Phentolamine, 
guanethidine and atropine (each 1 x 10 ^M) were present 
throughout.
Fig. 64; The effect of Ca^^-withdrawal from the
superfusing Krebs solution (for the period
indicated by the horizontal bar) on the H overflow
(upper graph) and simultaneously-recorded mechanical
relaxations (lower trace) of the guinea-pig i.a.s.,
evoked by field stimulation (9OO pulses at 2 and 5 Hz,
0.5 ms, supramaximal voltage). Removal of Ca^^
3
increased the resting H overflow and abolished
tone. Field stimulation now had no effect on either 
3
H overflow or mechanical activity. Phentolamine, 
guanethidine and atropine (each 1 x 10 ^M) were 
present throughout.
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Q
produced neither an increase in overflow nor a relaxation.
3
The rise in resting H overflow has also been seen following 
Ca withdrawal from other autonomically—innervated tissues 
(e.g. canine saphenous vein; Takata & Kato, 1984) and 
attributed to autonomic nerves (Soullin, I967). It may be 
due to a decrease in stability of the neuronal membrane or 
to an inhibition of the NANG transmitter uptake—1 mechanism.
Secondly, sodium nitroprusside (SNP, 1 x 10"^M), which 
relaxes smooth muscle independently of nerve activity, 
probably via an increase in cGMP (Bowman & Dorummond, 1984), 
reduced the tone of the i.a.s. without an accompanying increase 
in overflow (Fig. 63)»
As a consequence of the inhibitory effects of TTX (l x 10 ^M)
2+ 3and Ca -withdrawal on the stimulation-evoked increase in H
overflow and the failure of direct muscle relaxation by SNP
(1 X  10”^M) to affect the resting overflow, it is likely that 
3
the H arose from nerves. These nerves were NANC; the 
influence of the other, sympathetic, innervation in the i.a.s. 
was prevented by guanethidine (l x 10 ^M).
Verapamil was added to study the effects of Ca^* channel 
antagonists on overflow. Verapamil (l x 10“^M) abolished 
tone, but had no effect on the evoked overflow (Fig. 66).
At a higher concentration (l x lO'^M), the resting overflow 
was unaffected, while that evoked by stimulation was inhibited 
(Fig. 67). Thus, verapamil preferentially blocked the muscle 
response in comparison to transmitter release, as it did in 
the other tissues.
o<u
Cl
CD
C/D
CL
Q
7-,
6-
5-
4-
J w*:
•  90H7 9 \ m
A
20Hz
/
Z,
Y~T-
86
ig
1 min
SNP (1 X 10'^M)i
- i  1 r—
102 118
Time (min)
— T------ 1
134
A
irl U
Fig. 65; overflow (upper graph) and simultaneously-
recorded mechanical relaxations (lower trace) of the 
guinea-pig i.a.s., in response to field stimulation 
(900 pulses at 20 Hz, O .5 ms, supramaximal voltage) 
and to addition of sodium nitroprusside (SNP, 1 x 10"^M)
Sodium nitroprusside, unlike field stimulation, relaxed
3
the tissue without affecting H overflow. Phentolamine, 
guanethidine and atropine (each 1 x 10 ^M) were present 
throughout.
Verapamil (1 x 10'^M)
5 n
o
<D
Q.
CD
CO
CL
a
3 -
A
20Hz
20Hz
20Hz
20Hz % 
20Hz
^  1 1 1 1 1 1 1 1—
85 102 1 18 134 150
Time (min)
-6,Verapamil (1 x 10 M)
Iq
[ A
1 min
ii (JLAi w A j Jl.
Fig. 66; The effect of verapamil (l x 10"^M for 
the period indicated by the horizontal bar) on the 
overflow (upper graph) and simultaneously- 
recorded mechanical relaxations (lower trace) of 
the guinea-pig i.a.s., in response to field 
stimulation (900 pulses at 20 Hz, 0.5 ms, supramaximal 
voltage). Verapamil abolished the tone of the i.a.s., 
but had no inhibitory effect on the H overflow evoked 
by field stimulation. Phentolamine, guanethidine and 
atropine (each 1 x 10 ^M) were present throughout.
Pig. 67 : The effect of verapamil (l x 10 ^M) for
the period indicated by the horizontal bar) on the
overflow (upper graph) and simultaneously-recorded
mechanical relaxations (lower trace) of the guinea-pig
i.a.s., in response to field stimulation (9OO pulses
at 20 Hz, 0.3 ms, supramaximal voltage). Verapamil
abolished the tone of the i.a.s. and inhibited the 
3
H overflow evoked by field stimulation. The resting
3
H overflow was unaffected by verapamil. Phentolamine, 
guanethidine and atropine (each 1 x 10 ^M) were 
present throughout.
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The problem of the nature of the substance(s) released 
by stimulation remained. To separate and identify the [^h] -
compounds from the i.a.s., chromatography was used. The 
major constituents in the resting overflow were breakdown 
products of ATP; hypoxanthine, cAMP, AMP and adenosine and 
inosine (Fig. 68a). Field stimulation (24-00 pulses at 20 Hz,
0.3 ms, supramaximal voltage) released mainly hypoxanthine,
AMP and cAMP (Fig. 68b), while most of the in the tissue, 
itself, was incorporated into the nucleotides, ATP and ADP 
(Fig. 68c).
ATP AS A CANDIDATE FOR THE NANC TRANSMITTER IN THE GUINEA-PIG 
INTERNAL ANAL SPHINCTER
The presence of breakdown products of ATP in the overflow 
following field stimulation, was consistent with the view (Lim 
& Muir, 1986), that in the i.a.s., ATP is the NANC transmitter. 
In an attempt to detect ATP release from the NANC nerves, two 
further investigations were carried out.
(i) Analysis by thin layer chromatography
Even in the presence of the ATPase inhibitor, sodium 
vanadate (l x 10 ^M), thin layer chromatography failed to 
detect any ATP or its metabolites in samples of the superfused
1.a.s., collected either at rest or following field stimulation 
(1000 pulses at 10 Hz, 0.1 - 0.3 ms, supramaximal voltage).
It is likely that the sensitivity of this procedure was too
low; the standards, ATP, ADP, AMP, adenosine and inosine were
-9only detected at concentrations above 1 x 10 M.
ClŒm
Q .a
03-t-jo
A TP ADP AMP CA MP  H v D. A d . /I n . ATP ADP AMP C A M P  H v p . A d . /In, ATP ADP AMP CA MP  H v p .Ad . /In.
Fig. 68; The relative amounts (- s.e. mean, n = 4) of [^h ] - 
adenosine 3'-triphosphate ( [^h J -ATP) and its metabolites, 
each expressed as a percentage of the total DPM/sample, of
3
a. the H overflow at rest, b . following field stimulation 
(24-00 pulses at 20 Hz, 0.3 ms, supramaximal voltage) and
3
c. the H content of the guinea-pig i.a.s. following homo­
genisation. At rest, the major constituents were hypoxanthine 
(Hyp.), adenosine 3',3'-cyclic monophosphate (cAMP), adenosine 
3 ’-monophosphate (AMP) and adenosine and inosine (Ad./in.). 
Field stimulation released mainly hypoxanthine (Hyp.), AMP and
3
cAMP, while the H content of the i.a.s. consisted principally 
of ATP and adenosine 3'-diphosphate (ADP).
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(ii) Luciferase-luciferin luminescence
This technique was a sensitive assay for ATP; as little 
as 6 X 10 moles of ATP could be detected (Fig. 69)* Despite 
this sensitivity, NANC nerve stimulation (lOO - 1000 pulses at 
10 and 20 Hz, 0.2 ms, supramaximal voltage), while relaxing 
the i.a.s., failed to release a measurable amount of ATP.
Addition of sodium vanadate (l x 10 ^M) had no effect (Fig. 70).
This failure to detect ATP may have been due to either 
a lack of sensitivity of the technique, the metabolism of 
released ATP or, alternatively, may indicate that ATP is not 
the NANC transmitter. To investigate these alternatives, the 
luciferase-luciferin technique was applied to the guinea-pig 
vas deferens, as in this tissue, ATP is likely to be a 
transmitter (Burnstock & Sneddon, 1984; Sneddon & Westfall,
1984).
Field stimulation (200 pulses at 10 Hz, 0.2 ms, supramaximal 
voltage) of the guinea-pig vas deferens produced a TTX (2 x 10 ^M)- 
sensitive contraction and an accompanying increase in ATP 
release (Fig. ?l). To inhibit contractions of the vas deferens, 
which contribute to the release of ATP (Westfall ejb ad., 1978), 
a hypertonic Krebs solution containing sucrose (0.37M) was 
superfused. Field stimulation (200 pulses at 10 Hz, 0.2 ms, 
supramaximal voltage) in the presence of sucrose, when there 
were no contractions, failed to release any ATP (Fig. 72). It 
is likely, therefore, that in the absence of sucrose, ATP was 
released as a consequence of the muscle contraction rather 
than from nerves. In an attempt to detect neuronally-released 
ATP in the vas deferens, the ATPase inhibitor, sodium vanadate
Control 6 x 1 0 “^^ 1 . 8 x 1 0 “^^ moles ATP
Fig. 69: The degree of luciferase-luciferin luminescence
detected in samples (0.5 ml) of ATP (6 x 10~^^ - 1.8 x lo"^^ 
moles, dissolved in Krebs solution). Compared to the control 
(0.3 ml Krebs), ATP increased the amount of luminescence in 
a concentration-dependent manner.
Sodium Vanadate (1 xlO"^M)
Control 100/10 500/10
ig
1 min
1.0 ^ ^
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Fig. 70: The effect of field stimulation (lOO and 500 pulses
at 10 Hz and 1000 pulses at 20 Hz, 0.2 ms, supramaximal voltage) 
of the superfused guinea-pig i.a.s., on the mechanical activity 
(upper trace) and accompanying ATP release, in the absence
/ -4and presence of the ATPase inhibitor, sodium vanadate (1 x 10 M 
for the period indicated by the horizontal bar). Field 
stimulation, before and during addition of sodium vanadate, 
relaxed the i.a.s., but failed to produce any release of ATP. 
Samples from the superfused i.a.s. (0.5 ml), collected prior 
to stimulation, served as controls.
[
TTX (2x10“®M)
Ig
1 min
Control 200/10
#
Control
1 min
0.8 2. 
CD
0.4 3  
o
0 i
200/10
Fig. 71: The effect of field stimulation (200 pulses at
10 Hzf 0.2 ms> supramaximal voltage) of the superfused
guinea-pig vas deferens, on the mechanical activity (upper
trace) and accompanying ATP release, in the absence and
/ —  6presence of TTX (2 x 10 M for the period indicated by the 
horizontal bar). Field stimulation produced a contraction 
and a release of ATP, both of which were inhibited by TTX. 
Samples from the superfused vas deferens (0.5 ml), collected 
prior to stimulation, served as controls.
Sucrose (0.37M)
1 min
Control 200/10 200/10 200/10 Control 200/10 200/10 1 min
Ig
2.5
2.0 °  
0)
1.5 3
3I
1.0  ^  X
oI
0.5 3 
0
Pig. 72; The effect of field stimulation (200 pulses at 
10 Hz, 0.2 ms, supramaximal voltage) of the superfused 
guinea-pig vas deferens, on the mechanical activity (upper 
trace) and accompanying ATP release, in the absence and 
presence of sucrose (0.3?M for the period indicated by the 
horizontal bar) to inhibit, selectively, the contractions.
In the absence of sucrose, field stimulation contracted 
the vas deferens and released ATP. In the presence of 
sucrose, muscle tone increased, while contractions and ATP 
release, in response to field stimulation, were prevented. 
Samples from the superfused vas deferens (0.5 ml), collected 
prior to stimulation, served as controls.
Sucrose (0.37M)
Sodium Vanadate (1 x10~^M) 
and Dipyridamole (5 x10'^M)
ig
30s
Control 2000/20 Control 2000/20 Control 2000/20 30s
1 _  
X
o
I
0 -5
Fig. 73? The effect of field stimulation (2000 pulses at 
20 Hz» 0.2 ms, supramaximal voltage) of the superfused 
guinea-pig vas deferens, on the mechanical activity (upper 
trace) and accompanying ATP release. Sucrose (0.37M) was 
added to block contractions, sodium vanadate (1 x 10 ^M) 
to inhibit ATPase and dipyridamole (5 x 10 ^M) to prevent 
adenosine uptake. In the absence of drugs, field stimulation 
contracted the vas deferens and released ATP. In the presence 
of sucrose, either alone, or together with sodium vanadate 
and dipyridamole, muscle tone increased, while contractions 
and ATP release, in response to field stimulation, were 
prevented. Samples from the superfused vas deferens (0.5 ml), 
collected prior to stimulation, served as controls.
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/ —4 V(1 X 10 M) and adenosine uptake blocker, dipyridamole 
(5 X 10 ^M), were superfused in the presence of sucrose (0.37M) 
It was hoped that these compounds, by preventing the disappear­
ance of ATP, might allow its detection. Field stimulation 
(2000 pulses at 20 Hz, 0.2 ms, supramaximal voltage), however, 
in the presence of sodium vanadate, dipyridamole and sucrose 
failed to produce a detectable release of ATP (Fig. 73)*
_ 88 -
CHAPTER k : DISCUSSION
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The methods used in this investigation have clearly 
demonstrated that Ca^* channel antagonists possess prejunctional 
activity in autonomically-innervated smooth muscle. The use 
of nerve AP conduction, radiolabelled transmitter overflow 
and junction potentials in smooth muscle are accepted measures 
of prejunctional activity (Andersson ejk ad., I983; Bennett, 
1973; Cunnane & Stjârne, 1984), although, as with all 
experimental methods, each has its limitations. In this 
study, APs were unavoidably measured from preterminal, rather 
than terminal regions of nerves, due to the latter's inaccess­
ibility. The radiolabelled transmitter measured, may have 
included both neuronally- and extraneuronally-derived material, 
consisting of metabolites, as well as the transmitter itself. 
Measures were taken to overcome these problems. Sucrose, for 
example, was used to paralyse selectively the muscle response 
in radioisotope experiments (Westfall e_k al. , 1978), thereby 
minimizing its contribution to the overflow. TTX was used 
to inhibit and thus confirm the extent of neuronal involvement. 
Inhibitors of metabolism and uptake were used to reduce 
transmitter loss, and chromatographic techniques to identify 
the compound(s) collected.
The use of junction potentials as a measure of transmitter 
release is complicated by the contribution of postjunctional 
events. Clearly, any change in membrane potential of the 
smooth muscle will affect the amplitude of evoked potentials, 
as, for example, in the case of isoprenaline-induced enhancement 
of spontaneous m.e.p.ps at the skeletal neuromuscular junction
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(Kuba, 1970). In the present study, significant postjunctional 
involvement was unlikely. During blockade of either e.j.ps 
or i.j.ps by the organic Ca^^ channel antagonists, the ability 
of the postjunctional membrane to respond, electrically, 
to either noradrenaline or ATP was unimpaired.
The present investigation has clarified the principal 
prejunctional sites at which Ca^ '*’ channel antagonists act.
The organic compounds probably inhibited transmitter release 
by preventing invasion of the nerve terminals by the AP, rather 
than by interfering with the secretory process itself. In 
support of this view, similar concentrations of the drugs were 
required to prevent transmitter release and AP conduction in 
each tissue, while compounds ineffective on release, also 
failed to inhibit the APs, e.g. nifedipine in the vas deferens.
AP blockade may have arisen from an inhibition of Na"*" 
and/or Ca^ '*’ conductance. The ability of the antagonists to 
inhibit, at high concentrations, AP conduction was reminiscent 
of local anaesthetics, with which they have been compared 
(Bayer _et a^. , 1973; Hay & Wadsworth, 1982; Nagao ejb al. , 1972). 
Not surprisingly, therefore, the AP in the hypogastric nerve 
was blocked by TTX, but not by nifedipine, which lacks local 
anaesthetic activity (Hay & Wadsworth, I982). Moreover, 
cobalt, at the high concentrations required to inhibit APs 
in the hypogastric nerve, antagonises Na*, in addition to Ca^* 
influx (Edwards, 1982).
A Ca^ "*", as well as Na^ component, sensitive to the 
antagonists may, however, also be present in the AP. |ca^^j Q- 
withdrawal in the hypogastric nerve reduced, reversibly, AP
— 9-1 “
amplitude (seen also by Cunnane & Stjâme, 1984). Despite
their sensitivity to TTX, the APs in the genito-femoral nerve
were inhibited, not only by nifedipine, which has no local
anaesthetic activity (Hay & Wadsworth, I982), but also by
concentrations of cobalt close to those proposed to block
Ca^* channels selectively (Edwards, I982). The existence of 
+ 2 +Na and Ca components in the AP occurs in, for example, 
the postganglionic neurones of the rat superior cervical 
ganglion (McAfee & Yarowsky, 1979) and the axons of the Helix 
(Akaike ejb aT. , 1978) and squid (Hagiwara, 1973)* In these 
tissues, conductance mediated by Na'*" and Ca^^ involves different 
channels; a Ca^^-, but not Na^- mediated current remains 
following TTX addition. However, Ca^^ channels may allow the 
influx of Na^ (Hurwitz, I986; Reuter & Scholz, 1977)* la 
consequence, the possibility exists that in this study the 
Ca^* channel antagonists inhibited AP conduction by preventing 
both Na^ and Ca^^ influx through the same channel.
The ineffectiveness of the organic Ca^^ channel antagonists 
at the release site was surprising, since Ca^^ influx, which 
is required for the secretory process (Katz & Miledi, I965; 
Rubin, 1970) and occurs through V.O.Cs (Wakade & Wakade, I982), 
might have been expected to be sensitive. Difficulty of access 
to the Ca^^ channels at the nerve terminal could have been 
responsible, but is an unlikely explanation. More likely, 
the antagonists, themselves, may have had little affinity for 
the channels. There is no doubt that Ca^^ is involved. This 
was underlined by the ability of cobalt, in contrast to the 
organic agents, to inhibit transmitter release when preterminal
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nerve AP conduction was unaffected. Its site of action in 
these circumstances is, presumably, the terminal, rather than 
preterminal nerve regions.
Results from vivo experiments, designed to investigate 
the potential clinical value of the prejunctional actions of 
the organic antagonists, in the anaesthetised guinea-pig, 
were disappointing. It is unlikely that the prejunctional 
activity of the compounds investigated will be of clinical 
value. When given i.v. to block nerve AP conduction, each 
compound produced cardiovascular collapse. This investigation 
did, however, produce some interesting results. When AP 
conduction was inhibited, following close-arterial injection 
of verapamil, preganglionic transmitter release, rather than 
conduction itself, was prevented. Thus, acetylcholine (i.a.), 
added during blockade by verapamil, caused AP discharge. 
Clearly, the effectiveness of verapamil at the preganglionic 
nerve terminal contrasts with its ineffectiveness at the 
postganglionic release site. Although in agreement with 
previous studies which have investigated the effects of the 
organic agents at either site (GOthert e_fc ad., 1979; Ito & 
Nishi, 1982; O'Connor, 1982; Reinish e_t ad., I986), the 
reason why this should be so, is unclear.
Notwithstanding, however, the ability of the organic 
antagonists to act prejunctionally vivo and Ijn vitro is 
clearly secondary to their affinity for postjunctional sites. 
Cobalt, in contrast, was equally effective at either site. 
Thus, the organic compounds, but not cobalt, prevented evoked
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contractions, spontaneous muscle spikes and tone in the 
tissues investigated at doses lower than those required to 
block nerve AP conduction and transmitter release. This 
selectivity of the organic Ca^* channel antagonists is well 
known (Haeusler, 1972; Hëgestâtt e_fc al., 1982; Kajiwara & 
Casteels, I983) and suggests that the Ca^ "*" channels in smooth 
muscle differ from those at the nerve terminal. The nature 
of this difference is unclear. The proteins surrounding or 
lying within the channel - the organic antagonist binding 
sites (dossmann e_t ^ .  , I982, I983) - may be arranged 
differently at pre- and postjunctional locations. Presumably, 
the effectiveness of cobalt at each site reflects its ability, 
not shared by the organic agents, to compete directly with Ca^* 
for entry through the channel itself (Schramm & Towart, 1983)* 
This apparent heterogeneity in configuration is not restricted 
to Ca^^ channels; the different affinities of neuronal and 
muscular Na"*" channels for TTX may, it has been proposed, be
due to their structural differences (Baer ejt ad., 1976).
Differences in channel structure, moreover, may be analogous 
to those already accepted to exist between different receptors. 
Thus, the proteins which comprise the P-adrenergic and and 
muscarinic receptors, despite possessing similar amino acid 
sequences, are thought to be arranged in different configurations 
(Kubo e_fc ad., I986). This presumably explains the ability of 
drugs to act selectively at a particular receptor, e.g.
prazosin and yohimbine at a^- and aadrenoceptors respectively
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(Cambridge eJb al. , 1977; Langer, 1977)* la consequence, the 
discovery of an organic compound blocking selectively pre­
junctional Ca^^ channels is a possibility. The therapeutic 
value of such an antagonist is not in question. It could, 
by providing a potent means of controlling neuromuscular 
transmission, benefit the treatment of a variety of disorders, 
including angina pectoris and hypertension. Although problems 
restricting drug action to a particular tissue can be foreseen, 
the clinical promise of a prejunctionally-acting Ca^* channel 
antagonist should, in itself, be sufficient stimulus for 
future research. Investigation utilizing compounds chemically- 
related to the currently available drugs and employing 
appropriate measures of prejunctional activity, such as 
electrical and radiochemical analysis of transmitter release, 
may be the most rewarding.
Apparently quite unrelated to their inhibitory activity, 
organic Ca^ *^  channel antagonists stimulated catecholamine 
release from autonomic nerves. Such an action has been 
reported previously (Takata & Kato, 1984; Wolchinsky &
Zsoter, 1985)* It may be relevant clinically; elevation of 
noradrenaline levels could have several, potentially important, 
consequences. First, noradrenaline could stimulate vascular 
smooth muscle, attenuating the vasodilator and hypotensive 
effects of the antagonists. This could be achieved through 
R.O.Cs, which, unlike the V.O.Cs, are resistant to the organic 
antagonists (Flaim ^  ^ . , I983; Oriowo, 1984). Secondly, 
noradrenaline could augment the reflex tachycardia which 
follows the hypotensive effects of some of the drugs (Hof,
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1985)• In addition, as a consequence of depleting noradrenaline- 
containing stores, especially in the long-term, Ca^^ channel 
antagonists could detrimentally affect maintenance of sympathetic 
tone and influence cardiovascular performance. Significantly, 
elevation of plasma noradrenaline concentration occurs clinically, 
following administration of nifedipine and nitrendipine 
(Professor John Reid, personal communication; Ventura e_t al. , 
1983)» While, in the present investigation, the metabolite 
DOPEG was released, rather than noradrenaline itself, this 
compound could have been derived from noradrenaline, giving 
credence to these possibilities.
The mechanism responsible for the catecholamine release 
is unclear. The site of action was clearly neuronal; the 
effect of verapamil was reduced markedly following chemical 
sympathectomy by 6-hydroxydopamine. A non-specific reduction 
in the stability of the nerve terminals, with an accompanying 
liberation of transmitter, although a possibility, fails to 
explain why was released following [ h^ ] -noradrenaline, 
but not after [^ h ] -adenosine incubation. Two more likely 
explanations of what appears to be a selective, prejunctionally-
mediated, mechanism are a tyramine- or reserpine-like action.
3
Reminiscent of a tyramine action was the fast onset of H 
release and its independence of |ca^^j ^ . However, the presence 
of [^h] -DOPEG and absence of [^h] -noradrenaline in the 
overflow was inconsistent with this and more in keeping with 
a reserpine-like action (Kopin & Gordon, I962).
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Spontaneous release was not produced by the Ca^* channel 
antagonists following incubation with [^h] -adenosine, unlike 
the situation following labelling with noradrenaline. This 
allowed stimulation-evoked overflow in the vas deferens and
i.a.s., incubated with [^ h ] -adenosine, to be measured. The
3
amount of H released by nerve stimulation in each tissue 
was lower following labelling with adenosine than with 
noradrenaline. This may reflect the small quantity of ATP 
in the synaptic vesicles (in the vas deferens, estimated at 
l/^Oth of that of noradrenaline; Stjâme & Astrand, 1984). 
Alternatively, [^ h ] -adenosine may penetrate the nerve terminal 
poorly. The possibility cannot be ignored, however, that 
ATP may not have a transmitter role in either tissue (see 
later). At any rate, the present evidence confirmed the
3
release of H from nerves. In the vas deferens, when sucrose 
was added to paralyse the muscle (and so eliminate this as 
a source of ATP (Westfall e_fc aT., 1978) and TTX to remove
3
the neuronal contribution, no H was released by stimulation.
A similar situation occurred in the i.a.s., following muscle 
paralysis with verapamil and inhibition of neuronal conduction 
by TTX.
Together, the results in both the vas deferens and i.a.s. 
demonstrated neuronal release of ATP metabolites, rather than 
the nucleotide itself. The putative role of ATP as the NANC 
transmitter in each tissue (Burnstock & Sneddon, 1984; Lim 
& Muir, 1986) would be supported by detecting the release 
of intact ATP following stimulation. It was hoped that the 
highly sensitive luciferase-luciferin luminescence technique
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might achieve this. The results were, however, disappointing.
No neuronally-rel eased ATP in either the i.a.s. or vas 
deferens could be measured, even in the presence of the ATPase 
inhibitor, sodium vanadate (Cantley e_t al > , 1977)* This 
failure may be explained in at least one of three ways.
First, ATP may not be the transmitter in either tissue. 
Evidence to the contrary is, however, considerable. In the 
guinea-pig vas deferens, ATP mimics and a, me ATP, a compound 
which antagonises purinoceptors, blocks the depolarization and 
initial twitch component produced by nerve stimulation 
(Burnstock & Sneddon, 1984; Sneddon & Westfall, 1984). In 
the guinea-pig i.a.s., both ATP and NANC nerve stimulation 
hyperpolarize and relax the muscle by a Ca^^-dependent increase 
in conductance (Lim, I985; Lim & Muir, I986).
Alternatively, the amount of neuronally-released ATP may 
have been insufficient for detection by the luciferase- 
luciferin assay. However, considering that the ATP: noradrenaline 
ratio in the secretory vesicles of the vas deferens is claimed 
to be 1:50 (Stjâme & Astrand, 1984) and that each stimulus
—  1 o
should have released approximately 1 x 10 moles of
—18noradrenaline (Macrae, I985), this seems unlikely; 1 x 10 
moles of ATP could be detected easily by the assay.
The third and perhaps most likely explanation is that 
the ATP was metabolised following its release from nerves.
This is consistent with the recovery of [^h ] -ATP metabolites 
and the absence of the nucleotide itself, from the i.a.s. 
following NANG nerve stimulation. Failure of sodium vanadate
— 98 —
to protect ATP from destruction may reflect the complex nature
of ATP metabolism. The nucleotide is rapidly broken down at
2+ 2+the plasma membrane by at least three enzymes - Ca and Mg - 
ATPase, ^'-nucleotidase and Na"*^ and K^-ATPase (Manery & Dry den, 
1979) • The principal enzyme, Ca^ "*" and Mg^^-ATPase, has been 
identified in sympathetic nerves in the guinea-pig vas deferens 
(Burnstock, 1972) and non-myelinated nerves of the rat intestine 
(Rostgaard & Barmett, 1964) and retina (Marchesi e_fc aT. , 1964). 
The importance of this enzyme in ATP breakdown may explain 
the inability of sodium vanadate, which blocks selectively 
Na^ and K*-ATPase (Cantley e_t ad., 1977)» to allow accumulation 
of sufficient ATP.
Conclusions
The project was undertaken to investigate the influence 
of Ca^^ channel antagonists on autonomic neuromuscular 
transmission. The results showed that the compounds, albeit 
in high concentrations, inhibited both nerve AP conduction and 
transmitter release in the guinea-pig vas deferens and i.a.s. 
and the rat anococcygeus. The organic agents probably inhibited 
release by preventing invasion of the nerve terminals by the 
AP. They may have done so, by blocking Na^ and/or Ca^* 
involvement in the AP. In contrast, cobalt, it is likely, 
acted at or near the terminal to prevent Ca^^ influx and, in 
consequence, transmitter release. In each tissue, the organic 
agents, but not cobalt, acted postjunctionally at lower doses 
than those required to inhibit nerve APs and transmitter
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release. The possibility exists that in the future an 
organic Ca^* channel antagonist might be developed which would 
act selectively at prejunctional sites.
In the course of the investigation, the ability of the 
antagonists to stimulate spontaneous catecholamine liberation, 
in a manner analogous to that of tyramine or reserpine, was 
recognised. These experiments also allowed investigation of 
the nature of the transmitters in the guinea-pig vas deferens 
and i.a.s. Noradrenaline was released from the sympathetic 
nerves of the vas deferens. Also, the presence of a neuronally- 
mediated release of ^H, following incubation with [^h ] - 
adenosine, suggested that in both the vas deferens and i.a.s. 
this compound may have a transmitter role. Attempts to 
detect intact ATP from the nerves in either tissue were, 
however, disappointing, probably due to its metabolism. 
Unequivocal evidence that ATP is the NANC transmitter in the 
vas deferens or i.a.s., therefore, remains elusive.
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